lithium has been researched along with Affective Disorders in 330 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 143 (43.33) | 18.7374 |
| 1990's | 86 (26.06) | 18.2507 |
| 2000's | 51 (15.45) | 29.6817 |
| 2010's | 31 (9.39) | 24.3611 |
| 2020's | 19 (5.76) | 2.80 |
| Authors | Studies |
|---|---|
| Chandrasekaran, PK; O Brien, FM; Yan Qi, OW | 1 |
| Liaugaudaite, V; Mickuviene, N; Naginiene, R; Raskauskiene, N; Sher, L | 1 |
| Kuramochi, S; Mimura, M; Takeuchi, H; Uchida, H; Uchida, T; Yatomi, T | 1 |
| Fukushima, H; Matsuishi, K; Miura, A; Miyai, H; Mogi, K; Otani, K | 1 |
| Bojja, SL; Kolathur, KK; Rao, CM; Singh, N | 1 |
| Alamiri, B; Naguy, A | 1 |
| Moncrieff, J; Nabi, Z; Plöderl, M; Stansfeld, J; Wood, L | 1 |
| Bessa, G; Cousins, DA; Freitas, HLO; Juruena, MF; Kerr-Gaffney, J; Loschi, G; Pires, H; Strawbridge, R; Young, AH | 1 |
| Kyriacou, PA; Qassem, M; Sheikh, M | 1 |
| Ferensztajn-Rochowiak, E; Rybakowski, JK | 1 |
| Aki, M; Ando, T; Furukawa, TA; Katsuragi, K; Kawakami, K; Kawashima, H; Kawashima, T; Miki, T; Miyagi, T; Noma, S; Sawaki, Y; Seki, T; Tanaka, S; Ueno, S | 1 |
| Bélteczki, Z; Döme, P; Rihmer, Z | 1 |
| Manchia, M; Pinna, M; Tondo, L; Visioli, C | 1 |
| Anmella, G; Carpiniello, B; Carvalho, AF; Corponi, F; Del Matto, L; Fagiolini, A; Fico, G; Murru, A; Muscas, M; Pacchiarotti, I; Samalin, L; Verdolini, N; Vieta, E | 1 |
| Bokhan, NA; Epimakhova, EV; Losenkov, IS; Plotnikov, EV | 1 |
| Sakrajda, K; Szczepankiewicz, A | 1 |
| Rybakowski, J | 2 |
| Hashimoto, K; Hashimoto, R; Hashimoto, T; Hata, T; Hattori, K; Hishimoto, A; Horai, T; Idemoto, K; Ishima, T; Iyo, M; Kameno, Y; Kikuchi, M; Kimura, A; Minabe, Y; Mori, N; Nakagome, K; Niitsu, T; Oda, Y; Ota, K; Otsuka, I; Toda, S; Yamamori, H; Yoshida, S | 1 |
| Salisbury, E; Topp, S | 1 |
| Aljurdi, RK; Banerjee, S; Evans, LD; Gildengers, AG; Gur, RC; Gyulai, L; Marino, P; Mulsant, BH; Sajatovic, M; Schulberg, HC; Young, RC | 1 |
| Adler, M; Berglund, G; Böhm, B; Chotigasatien, A; Forsberg, L; Gustafsson, LL; Hammar, U; Ljungdahl, M; Navér, L; Römer Ek, I; Wide, K | 1 |
| Boyce, PM; Bryant, R; Fitzgerald, PB; Fritz, K; Hopwood, MJ; Lyndon, B; Malhi, GS; Morris, G; Mulder, R; Murray, G; Outhred, T; Porter, RJ; Singh, AB | 1 |
| Rzymski, P; Szklarska, D | 1 |
| Carrara, S; Criscuolo, F; Micheli, G; Taurino, I | 1 |
| Selo, M | 1 |
| Carmassi, C; Caruso, D; Del Grande, C; Dell'Osso, L; Fagiolini, A; Masci, I; Musetti, L | 1 |
| Börjesson, J; Gøtzsche, PC | 1 |
| Jha, V; Kohli, HS; Kumar, V; Nada, R; Rajakumar, V; Ramachandran, R; Rathi, M; Rawat, A; Sakhuja, V | 1 |
| Gray, JD; McEwen, BS | 1 |
| Atagün, MI; Oral, ET; Sevinç, C | 1 |
| Aiff, H; Attman, PO; Aurell, M; Bendz, H; Schön, S; Svedlund, J | 1 |
| Coffey, B | 1 |
| Holcroft, C; Looper, KJ; Low, NC; Mucsi, I; Rej, S; Segal, M; Shulman, K | 1 |
| Albanese, S; Amore, M; Baldessarini, RJ; Cicchella, D; De Vivo, B; Dinelli, E; Fiorillo, A; Girardi, P; Lima, A; Pompili, M; Pycha, R; Valera, P; Vichi, M | 1 |
| Clos, S; Cochrane, L; Donnan, PT; Rauchhaus, P; Severn, A | 1 |
| Costemale-Lacoste, JF; Gaillard, R; Guilloux, JP | 1 |
| Svoboda, P; Vosahlikova, M | 1 |
| Gorwood, P; Le Strat, Y; Olié, JP; Richard-Devantoy, S; Sentissi, O | 1 |
| Godart, N; Munch, G | 1 |
| Beaulieu, JM; Bureau, A; Chagnon, YC; Maziade, M; Paccalet, T | 1 |
| Boku, S; Koyama, T; Nakagawa, S | 1 |
| Glue, P; Herbison, P; Tarr, GP | 1 |
| Cassidy, EM; Clarkson, M; Dennison, U; O'Mullane, J | 1 |
| Kabacs, N; Memon, A; Obinwa, T; Perez, J; Stochl, J | 1 |
| Abdullah, O; Alabbas, H; Dackiw, AP; Kandil, E; Tufano, RP; Tufaro, AP | 1 |
| Austin, DR; Catapano, LA; Chen, G; Dosemeci, A; Luckenbaugh, DA; Manji, HK; Markey, SP; Nanavati, D | 1 |
| Adida, M; Budge, K; Geddes, JR; Goodwin, GM; McKnight, RF; Stockton, S | 1 |
| Berk, M; Malhi, GS | 1 |
| Cross, NB; Richardson, AK; Wells, JE | 1 |
| Bauer, M; Grof, P; Müller-Oerlinghausen, B | 1 |
| Lerer, B; Macciardi, F | 1 |
| Glitz, DA; Manji, HK; Moore, GJ | 1 |
| Duman, RS; Manji, HK | 1 |
| Halbreich, U; Kahn, LS; Mitwally, MF | 1 |
| Hisaoka, K; Morinobu, S; Nishida, A; Uchitomi, Y; Yamawaki, S; Zensho, H | 1 |
| Murck, H | 1 |
| Hegerl, U; Juckel, G | 1 |
| Du, J; Gray, NA; Manji, HK; Moore, GJ; Zhou, R | 1 |
| Baldessarini, RJ; Hennen, J; Tondo, L | 1 |
| Agam, G; Harwood, AJ | 1 |
| Koyama, T; Nakagawa, S | 1 |
| Dwight-Johnson, M; Lagomasino, IT; Simpson, GM | 1 |
| Müller-Oerlinghausen, B | 1 |
| Greil, W; Kleindienst, N | 1 |
| HARTIGAN, GP | 1 |
| SCHOU, M | 1 |
| Charney, DS; Denicoff, KD; Du, J; Gray, NA; Manji, HK; Quiroz, J; Singh, J; Zarate, CA | 1 |
| Bezchlibnyk, YB; Chen, B; MacQueen, GM; Wang, JF; Young, LT | 1 |
| Bredemeier, S; Frodl, T; Gallinat, J; Hegerl, U; Juckel, G; Mavrogiorgou, P; Möller, HJ; Schulz, C | 1 |
| Berry, GT; Buccafusca, R; Eccleston, E; Greer, JJ | 1 |
| Alevizos, B; Boufidou, F; Christodoulou, GN; Lorenzi, C; Malitas, PN; Mandelli, L; Nikolaou, C; Ploia, C; Serretti, A; Smeraldi, E | 1 |
| Birch, NJ | 1 |
| Lewis, FT | 1 |
| Gould, TD; Manji, HK | 1 |
| Okuma, T | 1 |
| Cipriani, A; Geddes, JR; Hawton, K; Pretty, H | 1 |
| Connemann, BJ | 1 |
| Einat, H; Gould, TD; Manji, HK; O'Donnell, KC; Picchini, AM; Schloesser, RJ | 1 |
| Garver, DL | 1 |
| Garfinkel, P; Roncari, I; Seltzer, A | 1 |
| Jakubowski, S; Tatham, A; Thomas, C | 1 |
| Lehmann, HE | 1 |
| LeRoy, A; Linnoila, M; MacDonald, E | 1 |
| Deyi, C; Jingsu, J; Shan-Ming, Y; Taylor, MA; Zhen, CY | 1 |
| Biederman, J; Jellinek, MS | 1 |
| Brockington, IF; Meltzer, HY | 1 |
| Sheard, MH | 1 |
| Kvale, JN | 1 |
| Linkowski, P; Mendlewicz, J; Uytdenhoef, P | 1 |
| Sarantidis, D; Waters, B | 1 |
| Arató, M; Felszeghy, K; Rihmer, Z | 1 |
| Prange, AJ; Whybrow, PC | 1 |
| Albano, JD; Millar, JG; Polak, A; Waller, DG | 1 |
| Coppen, A; Wood, K | 2 |
| Meltzer, HY | 1 |
| Thompson, C | 1 |
| DePaulo, JR | 1 |
| Berger, PA; Ciaranello, RD; Mefford, IN; Stahl, SM; Woo, DJ | 1 |
| Keisling, R | 1 |
| Berrettini, WH; Gershon, ES; Hare, TA; Nurnberger, JI; Post, RM; Simmons-Alling, S | 1 |
| Altman, EG; Duncavage, MB; Nasr, SJ | 1 |
| Abou-Saleh, M; Coppen, A; Milln, P; Swade, C; Wood, K | 1 |
| Colt, E; Decina, P; Fieve, RR; Oliver, JA; Sciacca, RR | 1 |
| Goodnick, P; Lowy, M; Meltzer, HY; Perline, R; Robertson, A | 1 |
| Dunner, DL | 2 |
| Ben-Aryeh, H; Gutman, D; Hefetz, A; Laor, R; Naon, H; Pascal, M; Szargel, R | 1 |
| Folger, WN; Massey, EW | 1 |
| Bennett, P; Latson, G; Logue, P; Miller, J; Schmitt, F; Shelton, D; Stoudemire, A | 1 |
| Hudson, JI; Jonas, JM; Pope, HG | 1 |
| Perris, C; Smigan, L | 1 |
| Roberts, DF; Watson, KC; Wentzel, J; Whalley, LJ | 1 |
| Binus, MH; Muniz, CE; Perillo, LJ; Troiano, AG | 1 |
| Alexander, B; Dunner, FJ; Perry, PJ; Prince, RA | 3 |
| Soucek, K; Zvolský, P | 1 |
| Malek-Ahmadi, P; Williams, JA | 1 |
| Mahy, Ge | 1 |
| Zhang, MY | 1 |
| Baxter, L; Gerner, R; Mazziotta, JC; Phelps, ME | 1 |
| Alvarez Martinez, E; Casas Brugue, M; Queralto Compano, JM; Udina Ubello, C | 1 |
| Ananth, J; Engelsmann, F; Ghadirian, AM | 1 |
| Akiskal, HS; Cassano, GB | 1 |
| Milanes, F; Okafor, KC; Slater, V; Talcott, V | 1 |
| Adam, W; Peker, J; Quasdorf, G | 1 |
| Alling, C; Aurell, M; Wallin, L | 1 |
| Chouinard, G | 1 |
| Coppen, A; Glover, V; Reveley, MA; Sandler, M | 1 |
| Lieb, J | 1 |
| Dunner, DL; Fieve, RR; Lautin, A; Peselow, ED | 1 |
| Davis, JM; Ostrow, DG | 1 |
| Kramer, PM; Martin, BA | 1 |
| Cloninger, CR; Cox, NJ; Dorus, E; Gibbons, RD; Pandey, GN; Shaughnessy, R | 1 |
| Leong, S; McCarthy, MJ; Menard, KN; Schacht, RG; Shopsin, B; Tyrer, SP | 1 |
| Abou-Saleh, MT; Coppen, A | 1 |
| Coppen, A; Price, RG | 1 |
| Klerman, GL | 1 |
| Elizur, A; Graff, E; Segal, Z; Yeret, A | 1 |
| Wehr, TA; Wirz-Justice, A | 1 |
| Shen, FH; Sherrard, DJ | 1 |
| Mendlewicz, J | 3 |
| Gasperini, M; Macciardi, F; Morabito, A; Smeraldi, E | 1 |
| Glen, AI; McGuire, RJ; Sashidharan, SP | 1 |
| Chee, KT; Kua, EH; Lee, SL | 1 |
| Grof, P; Jansky, L; Vyskocilova, J; Zvolsky, P | 1 |
| Czernik, A; Eberhard, A; Kleesiek, K | 1 |
| Correa, EI; DePaulo, JR; Sapir, DG | 1 |
| Maugh, TH | 1 |
| Del Vecchio, M; Farzati, B; Guida, L; Kemali, D; Maj, M; Minucci, P | 1 |
| Amsterdam, JD; Caroff, S; Levin, RM; Winokur, A | 1 |
| Grof, P; Rathbone, MP; Werstiuk, ES | 1 |
| Lieberman, KW; Stokes, P | 1 |
| Crouch, E | 1 |
| Karlberg, BE; Kjellman, BF; Thorell, LH | 1 |
| Post, RM | 2 |
| Dunner, DL; Fieve, RR; Goodnick, PJ; Meltzer, HL | 1 |
| Ahrens, B; Grof, P; Möller, HJ; Müller-Oerlinghausen, B; Wolf, T | 1 |
| Coupland, NJ; Nutt, DJ; Wilson, SJ | 1 |
| Levenson, J; Pandurangi, A; Silverman, J; Vieweg, V | 1 |
| Ahrens, B; Alda, M; Grof, E; Grof, P; Lenz, G; Müller-Oerlinghausen, B; Schou, M; Simhandl, C; Thau, K; Wolf, T | 1 |
| Healy, D; Waterhouse, JM | 1 |
| Lynn, DJ | 1 |
| Aurell, M; Balldin, J; Bendz, H; Mathé, AA; Sjödin, I | 1 |
| Beneke, M; Fritze, J; Lanczik, M; Schneider, B; Walden, J | 1 |
| Bothwell, RA; Eccleston, D; Marshall, E | 1 |
| Nixon, FE; Reeves, RR | 1 |
| Gross, R; Grunhaus, L | 1 |
| Müller-Oerlinghausen, B; Thies-Flechtner, K; Weigel, I | 1 |
| Stern, R | 1 |
| George, MS; Kling, MA; Post, RM; Rosenstein, D; Rubinow, DR | 1 |
| Heninger, GR; Price, LH | 1 |
| Adawi, A; Levy, A; Neumann, M; Shenkman, L; Shilo, L | 1 |
| Karas', SI; Kornetov, NA; Makarova, EV; Sherina, OL | 1 |
| Buffa, G; De Maio, D; Laviani, M; Levi-Minzi, A; Riva, M | 1 |
| Alda, M; Cameron, P; Fox, D; Grof, E; Grof, P | 1 |
| Abou-Saleh, MT | 1 |
| Ahrens, B; Grof, P; Müller-Oerlinghausen, B | 1 |
| Bagby, RM; Joffe, RT; Levitt, AJ; MacDonald, C; Singer, W | 1 |
| Franchini, L; Gasperini, M; Manfredonia, MG; Scherillo, P; Smeraldi, E | 1 |
| Hudson, CJ; Li, PP; Warsh, JJ; Young, LT | 1 |
| Nakayama, K; Yoshimuta, N | 1 |
| Annable, L; Bélanger, MC; Chouinard, G; Ghadirian, AM | 1 |
| Aurell, M; Bendz, H; Sjödin, I | 1 |
| Bocchetta, A; Cherchi, A; Del Zompo, M; Derai, R; Loviselli, A; Mossa, P; Velluzzi, F | 1 |
| Fujii, K; Inubushi, T; Kato, T; Shioiri, T; Takahashi, S | 1 |
| Post, RM; Weiss, SR | 1 |
| Alda, M; Cavazzoni, P; Duffy, A; Grof, E; Grof, P; Martin, R; Rouleau, G; Turecki, G | 1 |
| Prange, AJ | 1 |
| Johnson, G | 1 |
| Ahrens, B | 1 |
| Donders, SH; Meinardi, JR | 1 |
| Alda, M; Cavazzoni, P; Duffy, A; Grof, E; Grof, P; Martin, R; Ravindran, L | 1 |
| Adolfsson, R; Aström, M; Engström, C; Nordqvist-Karlsson, B; Nylander, PO | 1 |
| Bosquet, S; Descombes, E; Fellay, G; Gauthier, T; Regamey, C | 1 |
| Inubushi, T; Kato, N; Kato, T | 1 |
| Baldessarini, RJ; Jamison, KR; Tondo, L | 1 |
| Kilts, CD | 2 |
| Arngrim, T; Brodersen, A; Christensen, H; Grønvall, B; Kristensen, E; Licht, RW; Poulstrup, I; Rasmussen, NA; Vestergaard, P; Wentzer Licht, R | 1 |
| Coppen, A; Farmer, R | 1 |
| Dardennes, R; Even, C | 1 |
| Cervantes, P; Ghadirian, AM; Vida, S | 1 |
| Bebchuk, JM; Chen, G; Glitz, D; Hasanat, KA; Manji, HK; Moore, GJ | 1 |
| Jamison, KR; Simpson, SG | 1 |
| Nilsson, A | 1 |
| Berghöfer, A; Müller-Oerlinghausen, B | 2 |
| Goodwin, FK | 1 |
| Baldessarini, RJ; Jamison, KR | 1 |
| Deodhar, SD; Kulhara, P; Pathak, CM; Sharan, P; Singh, B | 1 |
| Bowden, CL | 1 |
| Corá-Locatelli, G; Frye, MA; Ketter, TA; Kimbrell, TA; Post, RM | 1 |
| Biollaz, J; Buclin, T; Dafflon, M; Décosterd, LA; Dufour, H; Preisig, M | 1 |
| Levinson, DF; Musthaq, M; Umapathy, C | 1 |
| Fillion, G; Fillion, MP; Januel, D; Massot, O; Plantefol, M; Rousselle, JC | 1 |
| Franchini, L; Gasperini, M; Smeraldi, E; Zanardi, R | 1 |
| Hardy, P; Pinabel, F | 1 |
| Harwood, AJ; Williams, RS | 1 |
| Kallner, G; Lindelius, R; Petterson, U; Stockman, O; Tham, A | 1 |
| Hardy, BG; Shulman, KI; Sproule, BA | 1 |
| Vestergaard, P | 1 |
| Jamison, KR | 1 |
| Kuroda, S; Lee, Y; Suzuki, H; Wada, K; Yamada, N | 1 |
| Avissar, S; Schreiber, G | 1 |
| Hegerl, U; Juckel, G; Mavrogiorgou, P; Schröter, A; Schulz, C | 1 |
| Dodds, G | 1 |
| Terao, T | 1 |
| Coppen, A | 2 |
| Gundlapalli, SP; Iqbal, MM; Passman, TE; Ryals, T; Ryan, WG | 1 |
| Burgess, S; Geddes, J; Goodwin, G; Hawton, K; Jamison, K; Townsend, E | 2 |
| Ahrens, B; Becker, T; Roick, C | 1 |
| Suzuki, K | 1 |
| Aberg-Wistedt, A; El-Khoury, A; Johnson, L; Mathé, AA; Stain-Malmgren, R | 1 |
| Lilli, R; Serretti, A; Smeraldi, E | 1 |
| Lilli, R; Lorenzi, C; Mandelli, L; Serretti, A; Smeraldi, E | 1 |
| Nomura, S | 1 |
| Serretti, A | 1 |
| Lilli, R; Lorenzi, C; Mandelli, L; Pirovano, A; Serretti, A; Smeraldi, E | 1 |
| Cosgrove, VE; Sachs, GS | 1 |
| Harrison, PJ | 1 |
| Cazzullo, CL; Sacchetti, E; Smeraldi, E | 1 |
| Corner, DA; Krska, J | 1 |
| Downes, CP; Sillence, DJ | 1 |
| Ceolin, L; Donnenfeld, AE; Jacobson, SJ; Johnson, K; Jones, K; Kaur, P; Rieder, M; Sahn, D; Santelli, R; Smythe, J | 1 |
| Henriksson, M; Isometsä, E; Lönnqvist, J | 1 |
| Bailey, J; Coppen, A; Houston, G; Silcocks, P | 1 |
| Johnson, L; Mathé, AA; Tham, A | 1 |
| Bourgeois, M; Peyre, F; Verdoux, H | 1 |
| Bar-Nathan, EA; Brenner, S; Ilie, B; Peyser, R; Srebrnik, A | 1 |
| Binder, EF; Birge, SJ; Cayabyab, L; Ritchie, DJ | 1 |
| Rapp, MS | 1 |
| Bailey, J; Coppen, A; Hermon, C; Houston, G; Silcocks, P; Standish-Barry, H | 1 |
| Lemere, F | 1 |
| Pary, RJ | 1 |
| Burnett, AK; Burns, F; Crocket, GT; Jenkins, C; McKillop, JH; Pearson, C; Thomson, JA; Wilson, R | 1 |
| Meltzer, HL | 1 |
| Amsterdam, JD; Maislin, G; Rybakowski, J | 1 |
| Waldmeier, PC | 1 |
| Smith, DF | 1 |
| Alexander, B; Cook, B | 1 |
| Evans, DL; Golden, RN; Haggerty, JJ; Nemeroff, CB; Pedersen, CA; Simon, JS | 1 |
| Armond, AD; Birch, NJ; Corbett, JA; Derham, C; King, JR; Myers, DH; Phillips, JD; Puranik, A | 1 |
| Mataga, N; Mitsushio, H; Takashima, M; Toru, M | 1 |
| Ikawa, K; Kariya, T; Motohashi, N | 1 |
| Emrich, HM; Lonati-Galligani, M; Pirke, KM; Raptis, C | 1 |
| Liu, ZZ; Mei, QY; Wan, Y | 1 |
| Akiskal, HS; Cassano, GB; Lazzerini, F; Lenzi, A; Placidi, GF | 1 |
| Atre-Vaidya, N; Taylor, MA | 1 |
| Denk, E; Lenz, G; Lovrek, A; Simhandl, C; Thau, K; Topitz, A; Wancata, J; Wolf, R | 1 |
| Schulze Mönking, H | 1 |
| Joyce, EM; Levy, R | 1 |
| Hanus, H; Kindernayová, H; Tůma, I; Zapletálek, M | 1 |
| Maling, TJ; McKeage, MJ | 1 |
| Lenox, RH | 1 |
| Abrams, R; Jampala, VC; Taylor, MA | 1 |
| Gaffney, GR; Tune, LE | 1 |
| Lawson, WB | 1 |
| Akiskal, HS; Davis, GC | 1 |
| Granzow, L; Greil, W; Haag, H; Haag, M | 1 |
| Godleski, LS; Vieweg, WV | 2 |
| Schou, M; Stengaard-Pedersen, K | 1 |
| Leonard, BE | 1 |
| Munir, KM | 1 |
| Aagaard, J; Maarbjerg, K; Vestergaard, P | 1 |
| Alvis, R; Amsterdam, JD; Braden, G; Cox, M; Geheb, M; Jorkasky, DK; Oler, J | 1 |
| Kalfoglu, G; König, W; Reimer, F; Rissom, R; Stein, A | 1 |
| Greil, W; Ludwig, W; Schmidt, S; Seibold, S | 1 |
| Kaschka, WP; Korth, M; Mokrusch, T; Thürauf, N | 1 |
| Müller-Oerlinghausen, B; Volk, J | 1 |
| Seggie, J | 1 |
| Cowdry, RW; Rosenthal, NE; Sack, DA; Wehr, TA | 1 |
| Brancato, V; Catalano, M; Gasperini, M; Lucca, A; Smeraldi, E | 1 |
| Chen, CC; Ko, WK | 1 |
| Dietch, JT; Rucker, L | 1 |
| Dilsaver, SC | 1 |
| Albani, G; Fattapposta, F; Morocutti, C; Rizzo, PA; Sanarelli, L; Valle, E | 1 |
| Boylan, MJ; Grindlinger, GA | 1 |
| Clemmesen, L; Hetmar, O; Ladefoged, J; Rafaelsen, OJ | 1 |
| DeForest, D; Tirrell, C | 1 |
| Hetmar, O; Rafaelsen, OJ | 1 |
| Addonizio, G; Roth, SD; Susman, VL | 1 |
| Murphy, DL; Nurnberger, JI; Pons, L | 1 |
| McCreadie, RG; Morrison, DP | 2 |
| Smigan, L | 1 |
| Davis, JM; Dorus, E; Gaviria, M; Gibbons, RD; Janicak, PG; Levy, DL; Pandey, GN; Shaughnessy, R; Yasillo, NJ | 1 |
| Banzhaf, M; Bertram, W; Schulze, F | 1 |
| Hull, RH | 1 |
| Batlle, DC; Gaviria, M; Grupp, M; von Riotte, AB | 1 |
| Correa, EI; Coyle, JT; DePaulo, JR; Gutterman, DF | 1 |
| Boulenger, JP; Nurnberger, J; Post, RM; Silberman, EK; Theodore, W | 1 |
| McCormick, M; McCreadie, RG; Morrison, DP | 1 |
| Arato, M; Brown, GM; Grof, E; Grof, P; Lane, J | 1 |
| Filion, M; Hillel, J | 1 |
95 review(s) available for lithium and Affective Disorders
| Article | Year |
|---|---|
What is the Role of Lithium in Epilepsy?
Topics: Epilepsy; Humans; Lithium; Lithium Compounds; Mood Disorders; Neuroprotection | 2022 |
Effects of lithium on suicide and suicidal behaviour: a systematic review and meta-analysis of randomised trials.
Topics: Bipolar Disorder; Humans; Lithium; Mood Disorders; Randomized Controlled Trials as Topic; Suicidal Ideation; Suicide, Attempted | 2022 |
Identifying the neuropsychiatric health effects of low-dose lithium interventions: A systematic review.
Topics: Adult; Antipsychotic Agents; Humans; Lithium; Mania; Mood Disorders | 2023 |
Lithium and suicide prevention in mood disorders and in the general population: A systematic review.
Topics: Antimanic Agents; Bipolar Disorder; Humans; Lithium; Mood Disorders; Prospective Studies; Retrospective Studies; Suicide Prevention | 2020 |
[Lithium in the psychopharmacology of affective disorders and mechanisms of its effects on cellular physiology].
Topics: Bipolar Disorder; Humans; Lithium; Mood Disorders; Psychopharmacology | 2020 |
Inflammation-Related Changes in Mood Disorders and the Immunomodulatory Role of Lithium.
Topics: Animals; Biomarkers; Cytokines; Disease Management; Disease Susceptibility; Energy Metabolism; Humans; Immunomodulation; Inflammation; Inflammation Mediators; Lithium; Mood Disorders | 2021 |
Lithium treatment - the state of the art for 2020.
Topics: Antipsychotic Agents; Bipolar Disorder; Depressive Disorder, Treatment-Resistant; Humans; Lithium; Lithium Compounds; Mood Disorders | 2020 |
Is Lithium a Micronutrient? From Biological Activity and Epidemiological Observation to Food Fortification.
Topics: Food, Fortified; Humans; Lithium; Micronutrients; Mood Disorders; Suicide Prevention | 2019 |
Lithium and valproate serum level fluctuations within the menstrual cycle: a systematic review.
Topics: Affect; Bipolar Disorder; Female; Humans; Lithium; Male; Menstrual Cycle; Mood Disorders; Valproic Acid | 2019 |
Effect of lithium on suicide and mortality in mood disorders: A systematic review.
Topics: Antimanic Agents; Databases, Bibliographic; Humans; Lithium; Mood Disorders; Placebos; Suicide; Suicide Prevention | 2019 |
Lithium's role in neural plasticity and its implications for mood disorders.
Topics: Antimanic Agents; Brain; Humans; Lithium; Mood Disorders; Neuronal Plasticity; Stress, Psychological | 2013 |
The role of GSK-3 in treatment-resistant depression and links with the pharmacological effects of lithium and ketamine: A review of the literature.
Topics: Antidepressive Agents; Depressive Disorder, Treatment-Resistant; Enzyme Inhibitors; Glycogen Synthase Kinase 3; Humans; Ketamine; Lithium; Mood Disorders | 2016 |
Lithium - therapeutic tool endowed with multiple beneficiary effects caused by multiple mechanisms.
Topics: Animals; Antidepressive Agents; Antimanic Agents; Bipolar Disorder; Depressive Disorder; Humans; Lithium; Mood Disorders | 2016 |
[Guidelines for the prescription of mood stabilizers for adolescents: A literature review].
Topics: Adolescent; Adolescent Psychiatry; Anticonvulsants; Antimanic Agents; Antipsychotic Agents; Humans; Lithium; Mood Disorders; Practice Guidelines as Topic; Practice Patterns, Physicians'; Psychotropic Drugs | 2017 |
Glucocorticoids and lithium in adult hippocampal neurogenesis.
Topics: Animals; Antimanic Agents; Disease Models, Animal; Glucocorticoids; Hippocampus; Humans; Lithium; Mood Disorders; Neurogenesis; Rats; Stress, Psychological | 2010 |
Comparative efficacy and acceptability of mood stabilizer and second generation antipsychotic monotherapy for acute mania--a systematic review and meta-analysis.
Topics: Affect; Antidepressive Agents; Antimanic Agents; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Double-Blind Method; Humans; Lithium; Lithium Carbonate; Lithium Compounds; Mood Disorders; Olanzapine; Randomized Controlled Trials as Topic; Valproic Acid | 2011 |
Lithium toxicity profile: a systematic review and meta-analysis.
Topics: Antipsychotic Agents; Humans; Lithium; Mood Disorders | 2012 |
Pharmacogenetics of antidepressant and mood-stabilizing drugs: a review of candidate-gene studies and future research directions.
Topics: Affect; Animals; Antidepressive Agents; Case-Control Studies; Depressive Disorder; Genome; Humans; Lithium; Mood Disorders; Pharmacogenetics; Research Design | 2002 |
Mood disorders: treatment-induced changes in brain neurochemistry and structure.
Topics: Brain; Brain Chemistry; Humans; Lithium; Magnetic Resonance Spectroscopy; Mood Disorders; Neurotransmitter Agents | 2002 |
Impairments of neuroplasticity and cellular resilience in severe mood disorders: implications for the development of novel therapeutics.
Topics: Animals; Antidepressive Agents; Apoptosis; Atrophy; Bipolar Disorder; Brain; Cell Membrane; Cell Survival; Glycogen Synthase Kinases; Hippocampus; Humans; Lithium; Magnetic Resonance Imaging; Mood Disorders; Neuronal Plasticity; Neuroprotective Agents; Psychotropic Drugs; Signal Transduction; Stress, Psychological | 2001 |
Pharmacotherapy of premenstrual syndromes and premenstrual dysphoric disorder: current practices.
Topics: Adrenergic beta-Antagonists; Anti-Anxiety Agents; Anti-Inflammatory Agents, Non-Steroidal; Antipsychotic Agents; Complementary Therapies; Diuretics; Female; Hormone Antagonists; Hormones; Humans; Lithium; Mood Disorders; Ovariectomy; Plant Preparations; Premenstrual Syndrome; Selective Serotonin Reuptake Inhibitors | 2002 |
Antidepressant drugs and cytokines in mood disorders.
Topics: Animals; Antidepressive Agents; Cytokines; Humans; Immune System; Lithium; Monoamine Oxidase Inhibitors; Mood Disorders | 2002 |
Magnesium and affective disorders.
Topics: Adrenal Glands; Animals; Behavior, Animal; Brain; Electroencephalography; Hippocampus; Homeostasis; Humans; Hypothalamus; Kindling, Neurologic; Lithium; Locus Coeruleus; Magnesium; Mood Disorders; Pituitary Gland; Sleep | 2002 |
Identifying psychiatric patients with serotonergic dysfunctions by event-related potentials.
Topics: Antimanic Agents; Evoked Potentials, Auditory; Humans; Lithium; Mental Disorders; Mood Disorders; Receptors, Serotonin; Selective Serotonin Reuptake Inhibitors; Synaptic Transmission | 2000 |
The use of mood stabilizers as plasticity enhancers in the treatment of neuropsychiatric disorders.
Topics: Anticonvulsants; Apoptosis; Atrophy; Brain; Central Nervous System Diseases; Gene Expression; Genes, bcl-2; Humans; Lithium; Mental Disorders; Mood Disorders; Neuronal Plasticity; Neurons; Signal Transduction; Valproic Acid | 2003 |
Lithium treatment and suicide risk in major affective disorders: update and new findings.
Topics: Bipolar Disorder; Depressive Disorder; Humans; Lithium; Mood Disorders; Risk Factors; Suicide; Suicide Prevention; Suicide, Attempted | 2003 |
Search for a common mechanism of mood stabilizers.
Topics: Affect; Animals; Anticonvulsants; Antimanic Agents; Carbamazepine; Glycogen Synthase Kinase 3; Humans; Inositol; Lithium; Mood Disorders; Signal Transduction; Valproic Acid | 2003 |
[Mechanism and clinical effects of drugs for mood disorder].
Topics: Antidepressive Agents; Antimanic Agents; Biogenic Monoamines; Humans; Inositol; Lithium; Meta-Analysis as Topic; Mood Disorders; Secondary Prevention; Synapses; Treatment Outcome; Valproic Acid | 2003 |
Underuse of evidence-based pharmacotherapies for affective disorders.
Topics: Antidepressive Agents, Tricyclic; Evidence-Based Medicine; Guideline Adherence; Health Services Misuse; Humans; Lithium; Monoamine Oxidase Inhibitors; Mood Disorders; Practice Guidelines as Topic; Societies, Medical | 2003 |
How should findings on antisuicidal effects of lithium be integrated into practical treatment decisions?
Topics: Algorithms; Antidepressive Agents; Health Care Costs; Humans; Lithium; Mood Disorders; Mortality; Odds Ratio; Suicide Prevention | 2003 |
Lithium in the long-term treatment of bipolar disorders.
Topics: Antimanic Agents; Bipolar Disorder; Humans; Lithium; Long-Term Care; Mood Disorders; Practice Patterns, Physicians'; Recurrence; Substance Withdrawal Syndrome; Treatment Outcome | 2003 |
Regulation of cellular plasticity cascades in the pathophysiology and treatment of mood disorders: role of the glutamatergic system.
Topics: Animals; Antidepressive Agents; Antimanic Agents; Glucocorticoids; Glutamates; Humans; Lithium; Mood Disorders; Neuronal Plasticity; Neurons; Receptors, AMPA; Signal Transduction; Stress, Psychological; Valproic Acid | 2003 |
The medical use of lithium.
Topics: Brain; Calcium; Depressive Disorder; Heart; Humans; Kidney; Lithium; Magnesium; Magnetic Resonance Spectroscopy; Mood Disorders; Skin Diseases; Tissue Distribution; Virus Diseases | 2004 |
Bipolar depression in primary care: a hidden threat.
Topics: Anticonvulsants; Antidepressive Agents; Antipsychotic Agents; Bipolar Disorder; Diagnosis, Differential; Humans; Lithium; Mood Disorders; Primary Health Care | 2004 |
Glycogen synthase kinase-3: a putative molecular target for lithium mimetic drugs.
Topics: Animals; Antidepressive Agents; Antipsychotic Agents; Circadian Rhythm; Disease Models, Animal; Electroconvulsive Therapy; Enzyme Inhibitors; Glycogen Synthase Kinase 3; Humans; Lithium; Models, Biological; Mood Disorders; Neurotransmitter Agents; Signal Transduction; Valproic Acid | 2005 |
[Investigation on the therapeutic effect of carbamazepine on the mood disorders in Japan].
Topics: Antidepressive Agents; Carbamazepine; Double-Blind Method; Humans; Japan; Lithium; Mood Disorders | 2005 |
Lithium in the prevention of suicidal behavior and all-cause mortality in patients with mood disorders: a systematic review of randomized trials.
Topics: Cause of Death; Confidence Intervals; Databases, Bibliographic; Humans; Lithium; Mood Disorders; Odds Ratio; Placebos; Randomized Controlled Trials as Topic; Suicide; Suicide Prevention; Treatment Outcome | 2005 |
Current concepts. Psychopharmacology in children.
Topics: Antidepressive Agents; Antipsychotic Agents; Anxiety Disorders; Attention Deficit Disorder with Hyperactivity; Central Nervous System Agents; Child; Child Behavior Disorders; Child Development Disorders, Pervasive; Enuresis; Feeding and Eating Disorders; Humans; Intellectual Disability; Lithium; Lithium Carbonate; Mental Disorders; Mood Disorders; Movement Disorders; Stereotyped Behavior | 1984 |
The nosology of schizoaffective psychosis.
Topics: Antipsychotic Agents; Bipolar Disorder; Chlorpromazine; Diagnosis, Differential; Diseases in Twins; Electroconvulsive Therapy; Humans; Lithium; Mood Disorders; Pedigree; Psychotic Disorders; Risk; Schizophrenia | 1983 |
Clinical pharmacology of aggressive behavior.
Topics: Adolescent; Adult; Aged; Aggression; Anger; Anti-Anxiety Agents; Benzodiazepines; Brain Chemistry; Carbamazepine; Child; Child Abuse; Child, Preschool; Epilepsy; Female; gamma-Aminobutyric Acid; Humans; Lithium; Male; Middle Aged; Mood Disorders; Prisoners; Propranolol; Psychotic Disorders | 1984 |
A hypothesis of thyroid-catecholamine-receptor interaction. Its relevance to affective illness.
Topics: Adenosine Monophosphate; Bipolar Disorder; Catecholamines; Depressive Disorder; Humans; Lithium; Mood Disorders; Norepinephrine; Receptors, Adrenergic; Receptors, Adrenergic, beta; Thyroid Hormones; Thyrotropin; Triiodothyronine | 1981 |
Serotonergic function in the affective disorders: the effect of antidepressants and lithium on the 5-hydroxytryptophan-induced increase in serum cortisol.
Topics: 5-Hydroxytryptophan; Antidepressive Agents; Antidepressive Agents, Tricyclic; Bipolar Disorder; Depression; Depressive Disorder; Humans; Hydrocortisone; Kinetics; Lithium; Monoamine Oxidase Inhibitors; Mood Disorders; Psychotic Disorders; Receptors, Serotonin; Serotonin; Suicide | 1984 |
Circadian rhythms and psychiatry.
Topics: Body Temperature; Circadian Rhythm; Depressive Disorder; Emotions; Humans; Hydrocortisone; Lithium; Mental Disorders; Mood Disorders; Sleep, REM | 1984 |
Lithium.
Topics: Aggression; Bipolar Disorder; Depressive Disorder; Dose-Response Relationship, Drug; Drug Therapy, Combination; Haloperidol; Humans; Hypothyroidism; Kidney; Lithium; Mood Disorders; Psychotic Disorders; Substance Withdrawal Syndrome | 1984 |
5-Hydroxytryptamine in the pathogenesis of affective disorders.
Topics: Antidepressive Agents, Tricyclic; Blood Platelets; Brain Chemistry; Electroconvulsive Therapy; Humans; Lithium; Monoamine Oxidase Inhibitors; Mood Disorders; Serotonin | 1982 |
Circadian rhythm mechanisms in affective illness and in antidepressant drug action.
Topics: Antidepressive Agents; Antidepressive Agents, Tricyclic; Bipolar Disorder; Circadian Rhythm; Humans; Lithium; Monoamine Oxidase Inhibitors; Mood Disorders; Sleep Deprivation; Sleep, REM | 1982 |
Use of selective serotonin reuptake inhibitors and other serotonergic drugs in the biological dissection of affective disorders.
Topics: Biomarkers; Blood Pressure; Depressive Disorder; Fluvoxamine; Heart Rate; Humans; Lithium; Lofepramine; Mood Disorders; Selective Serotonin Reuptake Inhibitors; Sleep Wake Disorders; Time Factors | 1995 |
The consulting psychiatrist and the polydipsia-hyponatremia syndrome in schizophrenia.
Topics: Angiotensin II; Anti-Inflammatory Agents, Non-Steroidal; Antipsychotic Agents; Carbamazepine; Cognition Disorders; Demeclocycline; Drinking Behavior; Electroconvulsive Therapy; Humans; Hyponatremia; Lithium; Mood Disorders; Naloxone; Phenytoin; Polyuria; Propranolol; Psychiatry; Psychotherapy; Schizophrenia; Sodium Chloride; Syndrome; Water Intoxication; Workforce | 1994 |
The circadian system and the therapeutics of the affective disorders.
Topics: Animals; Antidepressive Agents; Antipsychotic Agents; Behavior Therapy; Bipolar Disorder; Circadian Rhythm; Cognitive Behavioral Therapy; Depression; Humans; Lithium; Melatonin; Mood Disorders; Phototherapy; Seasonal Affective Disorder; Sleep | 1995 |
Lithium in the treatment of mood disorders.
Topics: Bipolar Disorder; Chemotherapy, Adjuvant; Depressive Disorder; Drug Interactions; Humans; Lithium; Mood Disorders | 1994 |
The challenge of predicting response to stabilising lithium treatment. The importance of patient selection.
Topics: Depressive Disorder; Female; Humans; Lithium; Male; Mood Disorders; Probability; Prognosis; Psychiatric Status Rating Scales; Psychotic Disorders; Treatment Outcome | 1993 |
Who responds to prophylactic lithium therapy?
Topics: Bipolar Disorder; Female; Humans; Lithium; Male; Mood Disorders; Probability; Treatment Outcome | 1993 |
CNS signal transduction in the pathophysiology and pharmacotherapy of affective disorders and schizophrenia.
Topics: Animals; Antidepressive Agents; Central Nervous System; Humans; Lithium; Mood Disorders; Phospholipids; Rats; Schizophrenia; Signal Transduction | 1993 |
A speculative model of affective illness cyclicity based on patterns of drug tolerance observed in amygdala-kindled seizures.
Topics: Affect; Amygdala; Animals; Anticonvulsants; Bipolar Disorder; Carbamazepine; Disease Progression; Drug Administration Schedule; Drug Evaluation, Preclinical; Drug Tolerance; Humans; Kindling, Neurologic; Lithium; Mood Disorders; Neurotransmitter Agents; Periodicity; Rats; Seizures; Valproic Acid | 1996 |
Novel uses of thyroid hormones in patients with affective disorders.
Topics: Antidepressive Agents; Bipolar Disorder; Electroconvulsive Therapy; Female; Humans; Levodopa; Lithium; Male; Mood Disorders; Parkinson Disease; Thyroid Diseases; Thyroid Gland; Thyroid Hormones | 1996 |
The role of lithium in the affective disorders.
Topics: Antidepressive Agents; Humans; Kidney; Lithium; Mood Disorders | 1996 |
Magnetic resonance spectroscopy in affective disorders.
Topics: Affect; Animals; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Basal Ganglia; Bipolar Disorder; Brain Chemistry; Depression; Energy Metabolism; Fluorine Radioisotopes; Frontal Lobe; Humans; Hydrogen; Lithium; Magnetic Resonance Spectroscopy; Membrane Lipids; Mood Disorders; Phosphorus Radioisotopes; Radioisotopes | 1998 |
Effect of lithium maintenance on suicidal behavior in major mood disorders.
Topics: Bipolar Disorder; Humans; Lithium; Mood Disorders; Risk Factors; Suicide Prevention; Treatment Outcome | 1997 |
The ups and downs of oral lithium dosing.
Topics: Administration, Oral; Brain; Brain Chemistry; Delayed-Action Preparations; Drug Administration Schedule; Humans; Lithium; Magnetic Resonance Spectroscopy; Mood Disorders; Tomography, Emission-Computed | 1998 |
[Current trends in the therapeutic use of thymic regulators].
Topics: Anticonvulsants; Antidepressive Agents; Depressive Disorder; Female; Humans; Lithium; Mood Disorders; Pregnancy; Pregnancy Complications; Valproic Acid | 1998 |
Modulation of CNS signal transduction pathways and gene expression by mood-stabilizing agents: therapeutic implications.
Topics: Bipolar Disorder; Calcium-Calmodulin-Dependent Protein Kinases; Carbamazepine; Gene Expression; Glycogen Synthase Kinases; Humans; Lithium; Mood Disorders; Protein Kinase C; Reverse Transcriptase Polymerase Chain Reaction; Signal Transduction; Tamoxifen; Transcription Factor AP-1; Valproic Acid | 1999 |
The risk of suicide in patients with bipolar disorders.
Topics: Alcoholism; Bipolar Disorder; Comorbidity; Cross-Cultural Comparison; Depressive Disorder; Female; Humans; Lithium; Male; Mood Disorders; Patient Discharge; Risk Factors; Suicide; Suicide Prevention; Suicide, Attempted; United States | 1999 |
Antidepressants and suicidal risk.
Topics: Antidepressive Agents; Cause of Death; Depressive Disorder; Humans; Lithium; Mood Disorders; Substance Withdrawal Syndrome; Suicide; Suicide Prevention; Suicide, Attempted | 1999 |
Anticonvulsant therapy and suicide risk in affective disorders.
Topics: Amitriptyline; Anticonvulsants; Bipolar Disorder; Carbamazepine; Double-Blind Method; Female; Follow-Up Studies; Humans; Lamotrigine; Lithium; Male; Mood Disorders; Prospective Studies; Risk Factors; Suicide; Suicide Prevention; Triazines; Valproic Acid | 1999 |
Metabolism and excretion of mood stabilizers and new anticonvulsants.
Topics: Anticonvulsants; Antimanic Agents; Carbamazepine; Drug Interactions; Drug Therapy, Combination; Humans; Lithium; Mood Disorders; Valproic Acid | 1999 |
Treatment of schizoaffective disorder and schizophrenia with mood symptoms.
Topics: Anticonvulsants; Antidepressive Agents; Antipsychotic Agents; Clinical Trials as Topic; Comorbidity; Depressive Disorder; Drug Therapy, Combination; Humans; Lithium; Mood Disorders; Psychotic Disorders; Schizophrenia; Schizophrenic Psychology; Treatment Outcome | 1999 |
[Lithium: principles and rules of use].
Topics: Bipolar Disorder; Contraindications; Depressive Disorder; Humans; Lithium; Mental Disorders; Mood Disorders; Schizophrenia; Time Factors | 1999 |
Differential pharmacokinetics of lithium in elderly patients.
Topics: Aged; Humans; Lithium; Mood Disorders | 2000 |
Suicide and bipolar disorder.
Topics: Adolescent; Adult; Bipolar Disorder; Female; Humans; Lithium; Male; Mental Disorders; Mood Disorders; Psychotherapy; Psychotropic Drugs; Risk Factors; Severity of Illness Index; Substance-Related Disorders; Suicide; Suicide Prevention; United States | 2000 |
Optimizing lithium treatment.
Topics: Adult; Bipolar Disorder; Cardiovascular Diseases; Cognition Disorders; Drug Administration Schedule; Drug Monitoring; Edema; Endocrine System Diseases; Gastrointestinal Diseases; Humans; Ichthyosis; Lithium; Mood Disorders; Neurotoxicity Syndromes; Patient Compliance; Tremor | 2000 |
G proteins as a biochemical tool for diagnosis and monitoring treatments of mental disorders.
Topics: GTP-Binding Proteins; Humans; Immunoblotting; Leukocytes, Mononuclear; Lithium; Mental Disorders; Mood Disorders; Receptors, Adrenergic, beta; Receptors, Dopamine; Receptors, Muscarinic; Signal Transduction; Tranquilizing Agents | 2000 |
Effects of antimanic mood-stabilizing drugs on fetuses, neonates, and nursing infants.
Topics: Abnormalities, Drug-Induced; Acetates; Adult; Amines; Antimanic Agents; Benzodiazepines; Breast Feeding; Carbamazepine; Cyclohexanecarboxylic Acids; Female; Fetus; Gabapentin; gamma-Aminobutyric Acid; Haloperidol; Humans; Infant, Newborn; Lithium; Mood Disorders; Olanzapine; Pirenzepine; Placenta; Pregnancy; Risk Factors; Valproic Acid | 2001 |
Lithium for maintenance treatment of mood disorders.
Topics: Antimanic Agents; Humans; Lithium; Mood Disorders; Placebo Effect; Randomized Controlled Trials as Topic | 2001 |
[Prophylactic long-term therapy of affective disorders with lithium, valproic acid and carbamazepine--effectiveness and cost-effectiveness].
Topics: Antimanic Agents; Carbamazepine; Cost-Benefit Analysis; Disease Management; Germany; Humans; Lithium; Mood Disorders; Randomized Controlled Trials as Topic; Retrospective Studies; Valproic Acid | 2001 |
Lithium for maintenance treatment of mood disorders.
Topics: Antimanic Agents; Bipolar Disorder; Humans; Lithium; Mood Disorders; Randomized Controlled Trials as Topic; Recurrence | 2001 |
Pharmacogenetics in affective disorders.
Topics: Animals; Antidepressive Agents; Antipsychotic Agents; Carrier Proteins; Genotype; GTP-Binding Proteins; Humans; Lithium; Membrane Glycoproteins; Membrane Transport Proteins; Mood Disorders; Nerve Tissue Proteins; Pharmacogenetics; Receptor, Serotonin, 5-HT2A; Receptors, Serotonin; Serotonin Plasma Membrane Transport Proteins | 2002 |
[Drug therapy for patients with mood disorders].
Topics: Antidepressive Agents; Cognitive Behavioral Therapy; Combined Modality Therapy; Drug Synergism; Drug Therapy, Combination; Evidence-Based Medicine; Humans; Lithium; Mood Disorders | 2001 |
Lithium long-term treatment in mood disorders: clinical and genetic predictors.
Topics: Carrier Proteins; Genetic Variation; Humans; Lithium; Membrane Glycoproteins; Membrane Transport Proteins; Mood Disorders; Nerve Tissue Proteins; Pharmacogenetics; Polymorphism, Genetic; Second Messenger Systems; Serotonin Plasma Membrane Transport Proteins; Time Factors | 2002 |
Bipolar disorder: current treatments and new strategies.
Topics: Acetates; Amines; Anticonvulsants; Bipolar Disorder; Cyclohexanecarboxylic Acids; Fructose; Gabapentin; gamma-Aminobutyric Acid; Humans; Lamotrigine; Lithium; Mood Disorders; Topiramate; Treatment Outcome; Treatment Refusal; Triazines | 1998 |
The neuropathology of primary mood disorder.
Topics: Brain; Brain Stem; Electroshock; Frontal Lobe; Hippocampus; Humans; Lithium; Mood Disorders | 2002 |
Perspectives and practical applications in psychopharmacogenetics.
Topics: Antidepressive Agents, Tricyclic; Humans; Lithium; Mental Disorders; Monoamine Oxidase Inhibitors; Mood Disorders; Pharmacogenetics; Psychotropic Drugs | 1979 |
Psychotropic drugs and their relationship with psychopathology of affective disorders.
Topics: Animals; Antidepressive Agents; Humans; Lithium; Methoxyhydroxyphenylglycol; Mood Disorders; Psychotropic Drugs | 1979 |
Early detection of high risk subjects in affective disorders.
Topics: Bipolar Disorder; Diseases in Twins; Environment; Female; Humans; Lithium; Male; Mood Disorders; Risk Factors | 1979 |
Mechanisms of the psychotropic action of lithium and carbamazepine.
Topics: Brain; Carbamazepine; Drug Synergism; Humans; Lithium; Mood Disorders | 1992 |
Towards defining adequate lithium trials for individuals with mental retardation and mental illness.
Topics: Aggression; Humans; Intellectual Disability; Lithium; Mood Disorders; Psychomotor Agitation | 1991 |
Mechanisms of action of lithium in affective disorders: a status report.
Topics: Animals; Humans; Lithium; Mood Disorders | 1990 |
Strategies in behavioral research on affective disorders: principles, problems and pitfalls.
Topics: Animals; Behavior; Humans; Lithium; Mood Disorders | 1990 |
Therapy of affective disorders.
Topics: Antidepressive Agents, Tricyclic; Combined Modality Therapy; Electroconvulsive Therapy; Humans; Lithium; Monoamine Oxidase Inhibitors; Mood Disorders | 1990 |
Effectiveness of lithium in schizophrenia: do we really have an answer?
Topics: Chronic Disease; Clinical Trials as Topic; Double-Blind Method; Humans; Lithium; Mood Disorders; Probability; Research Design; Schizophrenia | 1989 |
Racial and ethnic factors in psychiatric research.
Topics: Antidepressive Agents; Antipsychotic Agents; Asian; Bipolar Disorder; Black or African American; Black People; China; Creatine Kinase; Depressive Disorder; Dexamethasone; Ethnicity; Hispanic or Latino; HLA Antigens; HLA-A2 Antigen; Humans; Lithium; Mental Disorders; Monoamine Oxidase; Mood Disorders; Psychotropic Drugs; Racial Groups; Research; Schizophrenia; Thyrotropin-Releasing Hormone; United States | 1986 |
Biochemical aspects of therapy-resistant depression.
Topics: Antidepressive Agents, Tricyclic; Delusions; Depressive Disorder; Humans; Lithium; Mood Disorders; Serotonin | 1988 |
Lithium and the retina.
Topics: Dark Adaptation; Humans; Light; Lithium; Mood Disorders; Retina | 1988 |
Depression in primary care: evolving concepts and approach to therapy.
Topics: Antidepressive Agents, Tricyclic; Bipolar Disorder; Combined Modality Therapy; Depressive Disorder; Dexamethasone; Electroconvulsive Therapy; Humans; Lithium; Monoamine Oxidase Inhibitors; Mood Disorders; Neurocognitive Disorders; Primary Health Care; Psychotherapy | 1986 |
Pharmacologic induction of cholinergic system up-regulation and supersensitivity in affective disorders research.
Topics: Animals; Antidepressive Agents; Antidepressive Agents, Tricyclic; Bipolar Disorder; Brain; Depression; Desipramine; Female; Humans; Hypothalamo-Hypophyseal System; Limbic System; Lithium; Male; Mice; Mood Disorders; Parasympatholytics; Parasympathomimetics; Pupil; Rats; Receptors, Cholinergic; Research; Sleep, REM; Substance Withdrawal Syndrome | 1986 |
[Recent findings on lithium salts. Biochemical, neurophysiologic and clinico-therapeutic aspects].
Topics: Behavior; Headache; Humans; Lithium; Mental Disorders; Mood Disorders; Movement Disorders; Schizophrenia | 1986 |
20 trial(s) available for lithium and Affective Disorders
| Article | Year |
|---|---|
Electronic Health Record-Nested Reminders for Serum Lithium Level Monitoring in Patients With Mood Disorder: Randomized Controlled Trial.
Topics: Adult; Antipsychotic Agents; Electronic Health Records; Humans; Lithium; Mood Disorders | 2023 |
Assessing bipolar disorder in the older adult: the GERI-BD toolbox.
Topics: Aged; Antimanic Agents; Bipolar Disorder; Depressive Disorder, Major; Double-Blind Method; Drug Therapy, Combination; Female; Geriatric Assessment; Humans; Lithium; Male; Middle Aged; Mood Disorders; Valproic Acid | 2018 |
Effect of 5-hydroxytryptophan on serum cortisol levels in major affective disorders. III. Effect of antidepressants and lithium carbonate.
Topics: 5-Hydroxytryptophan; Antidepressive Agents; Antidepressive Agents, Tricyclic; Bipolar Disorder; Depressive Disorder; Humans; Hydrocortisone; Lithium; Lithium Carbonate; Monoamine Oxidase Inhibitors; Mood Disorders; Psychiatric Status Rating Scales; Receptors, Serotonin; Stimulation, Chemical | 1984 |
Extended survival of patients on long-term lithium treatment.
Topics: Adult; Aged; Bipolar Disorder; Cardiovascular Diseases; Cause of Death; Depressive Disorder; Female; Follow-Up Studies; Humans; Lithium; Male; Middle Aged; Mood Disorders; Psychotic Disorders; Suicide; Suicide Prevention; Survival Rate | 1995 |
Carbamazepine as adjunct or alternative to lithium in the prophylaxis of recurrent affective disorders.
Topics: Adult; Carbamazepine; Drug Therapy, Combination; Female; Humans; Lithium; Male; Mood Disorders; Recurrence; Retrospective Studies | 1994 |
Platelet intracellular calcium in patients with recurrent affective disorders.
Topics: Adult; Bipolar Disorder; Blood Platelets; Calcium; Depressive Disorder; Female; Humans; Lithium; Male; Mood Disorders; Psychiatric Status Rating Scales; Recurrence; Serotonin | 1994 |
5-HT uptake in platelets of lithium-treated patients with affective disorders and of healthy controls.
Topics: Blood Platelets; Female; Humans; In Vitro Techniques; Kinetics; Lithium; Male; Middle Aged; Mood Disorders; Serotonin | 1994 |
Renal function on and off lithium in patients treated with lithium for 15 years or more. A controlled, prospective lithium-withdrawal study.
Topics: Adult; Aged; Creatinine; Cross-Sectional Studies; Diabetes Insipidus; Female; Glomerular Filtration Rate; Humans; Kidney; Lithium; Male; Middle Aged; Mood Disorders; Prospective Studies; Substance Withdrawal Syndrome | 1996 |
Relationship between prophylactic effect of lithium therapy and family history of affective disorders.
Topics: Age of Onset; Antimanic Agents; Bipolar Disorder; Female; Humans; Lithium; Male; Middle Aged; Mood Disorders; Psychiatric Status Rating Scales | 1997 |
Outcome of lithium prophylaxis: a prospective follow-up of affective disorder patients assigned to high and low serum lithium levels.
Topics: Adult; Antidepressive Agents; Female; Follow-Up Studies; Humans; Lithium; Male; Middle Aged; Mood Disorders; Prospective Studies; Psychiatric Status Rating Scales; Treatment Outcome | 1998 |
Anticonvulsant therapy and suicide risk in affective disorders.
Topics: Amitriptyline; Anticonvulsants; Bipolar Disorder; Carbamazepine; Double-Blind Method; Female; Follow-Up Studies; Humans; Lamotrigine; Lithium; Male; Mood Disorders; Prospective Studies; Risk Factors; Suicide; Suicide Prevention; Triazines; Valproic Acid | 1999 |
Thyroid functions in lithium-treated psychiatric patients: a cross-sectional study.
Topics: Adolescent; Adult; Aged; Cross-Sectional Studies; Female; Humans; Iodine Radioisotopes; Lithium; Male; Middle Aged; Mood Disorders; Thyroid Gland; Thyrotropin; Thyroxine; Time Factors; Triiodothyronine | 1999 |
Mortality in 497 patients with affective disorders attending a lithium clinic or after having left it.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antimanic Agents; Bipolar Disorder; Cause of Death; Female; Humans; Lithium; Male; Middle Aged; Mood Disorders; Psychiatric Status Rating Scales; Suicide | 2000 |
Lithium-induced EEG changes in patients with affective disorders.
Topics: Aged; Antimanic Agents; Arousal; Electroencephalography; Female; Fourier Analysis; Functional Laterality; Humans; Lithium; Male; Middle Aged; Mood Disorders | 2000 |
Is there a loss of efficacy of lithium in patients treated for over 20 years?
Topics: Adult; Antimanic Agents; Bipolar Disorder; Female; Follow-Up Studies; Humans; Lithium; Male; Middle Aged; Mood Disorders; Psychiatric Status Rating Scales | 2000 |
Tryptophan depletion in lithium-stabilized patients with affective disorder.
Topics: Adrenocorticotropic Hormone; Adult; Affect; Aged; Amino Acids; Antimanic Agents; Bipolar Disorder; Double-Blind Method; Female; Humans; Hydrocortisone; Lithium; Male; Middle Aged; Mood Disorders; Prolactin; Serotonin; Tryptophan | 2001 |
Prospective multicentre study of pregnancy outcome after lithium exposure during first trimester.
Topics: Abnormalities, Drug-Induced; Adolescent; Adult; Female; Follow-Up Studies; Humans; Lithium; Mood Disorders; Pregnancy; Pregnancy Complications; Pregnancy Trimester, First; Prospective Studies | 1992 |
Role of hereditary, clinical and pharmacokinetic factors for the prediction of lithium prophylactic effect. WHO Collaborative Study.
Topics: Clinical Protocols; Female; Humans; Lithium; Lithium Carbonate; Male; Mood Disorders; Multicenter Studies as Topic; Prospective Studies; Psychotic Disorders; Research Design | 1989 |
Predictors of compliance with lithium and carbamazepine regimens in the long-term treatment of recurrent mood and related psychotic disorders.
Topics: Aged; Aged, 80 and over; Carbamazepine; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Lithium; Middle Aged; Mood Disorders; Patient Compliance; Psychotic Disorders; Random Allocation | 1989 |
Effectiveness of lithium in schizophrenia: do we really have an answer?
Topics: Chronic Disease; Clinical Trials as Topic; Double-Blind Method; Humans; Lithium; Mood Disorders; Probability; Research Design; Schizophrenia | 1989 |
217 other study(ies) available for lithium and Affective Disorders
| Article | Year |
|---|---|
The cascade to a serendipitous discovery of lithium-induced nephrogenic diabetes insipidus.
Topics: Aged; Bipolar Disorder; Diabetes Insipidus, Nephrogenic; Diabetes Mellitus; Female; Humans; Lithium; Long Term Adverse Effects; Mood Disorders | 2021 |
Association between lithium levels in drinking water and suicide rates: Role of affective disorders.
Topics: Drinking Water; Humans; Incidence; Lithium; Mood Disorders; Suicide | 2022 |
Drug Combinations for Mood Disorders and Physical Comorbidities That Need Attention: A Cross-Sectional National Database Survey.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Cross-Sectional Studies; Drug Combinations; Humans; Lithium; Mirtazapine; Mood Disorders; Selective Serotonin Reuptake Inhibitors; Serotonin and Noradrenaline Reuptake Inhibitors | 2022 |
Medical comorbidities leading to hypernatremia during COVID-19 pandemic in patients with mood disorders on long-term lithium therapy.
Topics: Bipolar Disorder; COVID-19; Humans; Hypernatremia; Lithium; Lithium Carbonate; Mood Disorders; Pandemics | 2022 |
Lithium Beyond Bipolar Mood Disorders: A Hope or Hype?
Topics: Antimanic Agents; Bipolar Disorder; Humans; Lithium; Lithium Compounds; Mood Disorders | 2022 |
Optical determination of lithium therapeutic levels in micro-volumes of interstitial fluid.
Topics: Animals; Bipolar Disorder; Extracellular Fluid; Humans; Lithium; Mood Disorders; Reproducibility of Results; Swine | 2023 |
Updated perspectives on how and when lithium should be used in the treatment of mood disorders.
Topics: Antidepressive Agents; Bipolar Disorder; Depressive Disorder; Humans; Lithium; Mood Disorders | 2023 |
[Fortification of drinking water with lithium to reduce suicide in the population].
Topics: Antimanic Agents; Drinking Water; Humans; Lithium; Mood Disorders; Suicide | 2023 |
Clinical response and metabolic effects of lithium in 323 mood disorder patients.
Topics: Aged; Antimanic Agents; Bipolar Disorder; Female; Humans; Italy; Lithium; Male; Mood Disorders; Retrospective Studies | 2020 |
Serum levels of glial cell line-derived neurotrophic factor as a biomarker for mood disorders and lithium response.
Topics: Biomarkers; Cross-Sectional Studies; Depressive Disorder, Major; Glial Cell Line-Derived Neurotrophic Factor; Humans; Lithium; Mood Disorders | 2021 |
Lithium use in a patient on haemodialysis with bipolar affective disorder and lithium-induced nephropathy.
Topics: Antimanic Agents; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Humans; Kidney Diseases; Lithium; Male; Mood Disorders; Neoplasm Recurrence, Local; Renal Dialysis; Valproic Acid | 2021 |
Maternal mood disorders and lithium exposure in utero were not associated with poor cognitive development during childhood.
Topics: Academic Medical Centers; Adult; Bipolar Disorder; Child; Cluster Analysis; Cohort Studies; Female; Follow-Up Studies; Humans; Infant Health; Infant, Newborn; Intelligence Tests; Lithium; Male; Mood Disorders; Pregnancy; Pregnancy Outcome; Pregnancy, High-Risk; Prenatal Care; Prenatal Exposure Delayed Effects; Regression Analysis; Retrospective Studies; Sweden; Time Factors | 2018 |
Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for mood disorders: bipolar disorder summary.
Topics: Antidepressive Agents; Antimanic Agents; Antipsychotic Agents; Australia; Bipolar Disorder; Combined Modality Therapy; Humans; Lithium; Mood Disorders; New Zealand; Secondary Prevention; Societies, Medical; Suicide Prevention | 2018 |
A novel electrochemical sensor for non-invasive monitoring of lithium levels in mood disorders.
Topics: Drug Monitoring; Electrodes; Humans; Lithium; Mood Disorders; Sweat | 2018 |
Happy 50th Anniversary, Lithium Clinics: The Perspective of a Long-Time User.
Topics: Clinical Trials as Topic; Germany; History, 20th Century; History, 21st Century; Humans; Lithium; Longitudinal Studies; Mood Disorders | 2018 |
IgG4-related tubulointerstitial nephritis presenting with psychiatric manifestations and skin lesions.
Topics: Anti-Inflammatory Agents; Antipsychotic Agents; Humans; Immunoglobulin G; Lithium; Male; Mood Disorders; Nephritis, Interstitial; Plasma Cells; Prednisolone; Skin Diseases; Young Adult | 2014 |
[Polycystic kidney disease in a patient using lithium chronically].
Topics: Creatinine; Humans; Lithium; Mood Disorders; Polycystic Kidney Diseases | 2013 |
End-stage renal disease associated with prophylactic lithium treatment.
Topics: Aged; Aged, 80 and over; Antidepressive Agents; Antimanic Agents; Causality; Cohort Studies; Comorbidity; Cross-Sectional Studies; Drug Prescriptions; Female; Humans; Kidney Failure, Chronic; Lithium; Male; Middle Aged; Mood Disorders; Prevalence; Registries; Risk; Secondary Prevention; Sweden | 2014 |
Challenges in psychopharmacological management of a young child with multiple comorbid disorders, history of trauma, and early-onset mood disorder: the role of lithium.
Topics: Age of Onset; Antipsychotic Agents; Child; Child Behavior Disorders; Comorbidity; Female; Humans; Lithium; Mood Disorders | 2014 |
In this correspondence, preliminary data in 100 lithium users found that urine osmolality correlated with chronic kidney disease, diabetes mellitus, and hypothyroidism. We hypothesize that GSK-3β inhibition is a potential mechanism for lithium-associated
Topics: Adult; Aged; Aged, 80 and over; Diabetes Mellitus; Female; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Humans; Hypothyroidism; Lithium; Male; Middle Aged; Mood Disorders; Osmolar Concentration; Renal Insufficiency, Chronic; Urine | 2015 |
Relationships of local lithium concentrations in drinking water to regional suicide rates in Italy.
Topics: Drinking Water; Female; Humans; Italy; Linear Models; Lithium; Male; Mood Disorders; Multivariate Analysis; Quality of Life; Risk Assessment; Sex Distribution; Suicide | 2015 |
Long-term effect of lithium maintenance therapy on estimated glomerular filtration rate in patients with affective disorders: a population-based cohort study.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Cohort Studies; Female; Glomerular Filtration Rate; Humans; Lithium; Male; Middle Aged; Mood Disorders; Time Factors; Treatment Outcome; Young Adult | 2015 |
The number of past manic episodes is the best predictor of antidepressant-emergent manic switch in a cohort of bipolar depressed patients.
Topics: Adult; Affect; Aged; Antidepressive Agents; Antimanic Agents; Bipolar Disorder; Carbamazepine; Depression; Female; Humans; Lithium; Middle Aged; Mood Disorders | 2016 |
The interaction of GSK3B and FXR1 genotypes may influence the mania and depression dimensions in mood disorders.
Topics: Adult; Age of Onset; Bipolar Disorder; Depressive Disorder, Major; Diagnostic and Statistical Manual of Mental Disorders; Female; Genotype; Glycogen Synthase Kinase 3 beta; Humans; Lithium; Male; Middle Aged; Mood Disorders; Polymorphism, Genetic; Prevalence; RNA-Binding Proteins | 2017 |
The incidence and clinical correlates of lithium toxicity: a retrospective review.
Topics: Adult; Aged; Aged, 80 and over; Confusion; Female; Humans; Lithium; Male; Middle Aged; Mood Disorders; Retrospective Studies; Standard of Care; Tremor | 2011 |
Lithium in drinking water and suicide rates across the East of England.
Topics: Adult; Antidepressive Agents; England; Female; Humans; Lithium; Male; Mood Disorders; Suicide; Water Supply | 2011 |
A profile of patients with hyperparathyroidism undergoing lithium therapy for affective psychiatric disorders.
Topics: Adult; Aged; Antipsychotic Agents; Calcium; Female; Humans; Hyperparathyroidism; Hyperplasia; Lithium; Middle Aged; Mood Disorders; Parathyroid Glands; Retrospective Studies | 2011 |
The effects of chronic treatment with mood stabilizers on the rat hippocampal post-synaptic density proteome.
Topics: Animals; Antipsychotic Agents; Drug Administration Schedule; Gene Regulatory Networks; Hippocampus; Lithium; Male; Mood Disorders; Post-Synaptic Density; Proteome; Rats; Rats, Inbred WKY; Treatment Outcome; Valproic Acid | 2011 |
Is the safety of lithium no longer in the balance?
Topics: Antipsychotic Agents; Humans; Lithium; Mood Disorders | 2012 |
Toxicity profile of lithium.
Topics: Antipsychotic Agents; Humans; Lithium; Mood Disorders | 2012 |
Commentary on a recent review of lithium toxicity: what are its implications for clinical practice?
Topics: Antipsychotic Agents; Humans; Lithium; Mood Disorders | 2012 |
THE USE OF LITHIUM SALTS IN AFFECTIVE DISORDERS.
Topics: Antipsychotic Agents; Bipolar Disorder; Depression; Geriatrics; Humans; Lithium; Mood Disorders; Psychotic Disorders; Salts; Toxicology | 1963 |
NORMOTHYMOTICS, "MOOD-NORMALIZERS": ARE LITHIUM AND THE IMIPRAMINE DRUGS SPECIFIC FOR AFFECTIVE DISORDERS?
Topics: Antipsychotic Agents; Bipolar Disorder; Depression; Depressive Disorder; Electrocardiography; Emotions; Humans; Imipramine; Lithium; Mood Disorders; Psychotic Disorders | 1963 |
Amygdala cyclic adenosine monophosphate response element binding protein phosphorylation in patients with mood disorders: effects of diagnosis, suicide, and drug treatment.
Topics: Adult; Age Factors; Aged; Amygdala; Blotting, Western; Case-Control Studies; Cell Count; Cyclic AMP Response Element-Binding Protein; Female; Humans; Immunohistochemistry; Lithium; Male; Middle Aged; Mood Disorders; Phosphorylation; Schizophrenia; Staining and Labeling; Suicide | 2004 |
Loudness dependence of primary auditory-cortex-evoked activity as predictor of therapeutic outcome to prophylactic lithium treatment in affective disorders--a retrospective study.
Topics: Adult; Antimanic Agents; Auditory Cortex; Electroencephalography; Evoked Potentials, Auditory; Female; Humans; Lithium; Male; Middle Aged; Mood Disorders; Predictive Value of Tests; Reference Values; Retrospective Studies; Treatment Outcome | 2004 |
Phosphoinositide deficiency due to inositol depletion is not a mechanism of lithium action in brain.
Topics: Animals; Brain; In Vitro Techniques; Inositol; Lithium; Mice; Mice, Knockout; Mood Disorders; Phosphatidylinositols; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Symporters; Tissue Extracts | 2004 |
Further evidence for a possible association between serotonin transporter gene and lithium prophylaxis in mood disorders.
Topics: Age of Onset; Antidepressive Agents; Bipolar Disorder; Female; Genotype; Humans; Lithium; Male; Membrane Glycoproteins; Membrane Transport Proteins; Middle Aged; Mood Disorders; Nerve Tissue Proteins; Polymerase Chain Reaction; Psychotic Disorders; Serotonin Plasma Membrane Transport Proteins; Thyroid Diseases | 2004 |
Lithium and suicidality revisited.
Topics: Humans; Lithium; Meta-Analysis as Topic; Mood Disorders; Randomized Controlled Trials as Topic; Research Design; Suicide Prevention | 2006 |
Beta-catenin overexpression in the mouse brain phenocopies lithium-sensitive behaviors.
Topics: Animals; Antimanic Agents; Behavior, Animal; beta Catenin; Brain; Disease Models, Animal; Genetic Predisposition to Disease; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Lithium; Mice; Mice, Transgenic; Mood Disorders; Phenotype; Psychomotor Agitation; Up-Regulation | 2007 |
A psychobiologic perspective in treating psychiatric disorders.
Topics: Anxiety Disorders; Clonidine; Humans; Lithium; Mental Disorders; Mood Disorders; Psychotic Disorders; Receptors, GABA-A; Substance Withdrawal Syndrome | 1984 |
Effect of patient education on medication compliance.
Topics: Adolescent; Adult; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Bipolar Disorder; Female; Humans; Lithium; Male; Mental Disorders; Middle Aged; Mood Disorders; Patient Compliance; Patient Education as Topic; Psychotropic Drugs; Schizophrenia | 1980 |
Lithium/haloperidol combinations and brain damage.
Topics: Brain; Drug Therapy, Combination; Haloperidol; Humans; Lithium; Mental Disorders; Middle Aged; Mood Disorders | 1982 |
Affective disorders in the aged.
Topics: Adjustment Disorders; Affective Disorders, Psychotic; Aged; Antidepressive Agents, Tricyclic; Bipolar Disorder; Depressive Disorder; Diagnosis, Differential; Humans; Life Change Events; Lithium; Monoamine Oxidase Inhibitors; Mood Disorders; Neurotransmitter Agents | 1982 |
Failure of lithium to counteract vanadate-induced inhibition of red blood cell membrane Na+, K+-ATPase.
Topics: Erythrocyte Membrane; Erythrocytes; Humans; Lithium; Mood Disorders; Sodium-Potassium-Exchanging ATPase; Vanadates; Vanadium | 1982 |
Prevalence and characteristics of mania in Chinese inpatients: a prospective study.
Topics: Adult; Affective Disorders, Psychotic; Antipsychotic Agents; Bipolar Disorder; China; Cross-Cultural Comparison; Female; Hospitals; Humans; Lithium; Male; Mood Disorders; Prospective Studies; Risk; Schizophrenia; United States | 1982 |
Psychoactive drugs and the frail elderly patient.
Topics: Aged; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Anxiety Disorders; Delirium; Depressive Disorder; Depressive Disorder, Major; Dyskinesia, Drug-Induced; Electroconvulsive Therapy; Humans; Lithium; Mood Disorders; Psychotherapy; Psychotropic Drugs; Sleep Wake Disorders | 1984 |
Biological quantitative methods in the evaluation of psychiatric treatment: some biochemical criteria.
Topics: Antidepressive Agents, Tricyclic; Antipsychotic Agents; Catechol O-Methyltransferase; Electroconvulsive Therapy; Humans; Hydroxyindoleacetic Acid; Lithium; Methoxyhydroxyphenylglycol; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Mood Disorders; Neurotransmitter Agents; Prognosis; Schizophrenia | 1982 |
A review and controlled study of cutaneous conditions associated with lithium carbonate.
Topics: Acne Vulgaris; Adult; Age Factors; Anxiety Disorders; Drug Eruptions; Female; Humans; Lithium; Lithium Carbonate; Male; Mood Disorders; Psoriasis; Sex Factors; Skin Diseases; Time Factors | 1983 |
Reduced plasma cyclic AMP level during prophylactic lithium treatment in patients with affective disorders.
Topics: Adult; Aged; Cyclic AMP; Female; Humans; Lithium; Male; Middle Aged; Mood Disorders; Remission, Spontaneous | 1980 |
Impairment of cyclic AMP response to bovine parathyroid hormone in patients on chronic lithium therapy with diminished renal urine-concentrating ability.
Topics: Adult; Aged; Chronic Disease; Cyclic AMP; Deamino Arginine Vasopressin; Female; Humans; Kidney Concentrating Ability; Kidney Diseases; Kidney Function Tests; Lithium; Male; Middle Aged; Mood Disorders; Parathyroid Hormone; Time Factors | 1983 |
Prophylactic lithium treatment of patients with affective disorders is associated with decreased platelet [3H]dihydroergocryptine binding.
Topics: Blood Platelets; Dihydroergotoxine; Female; Humans; Lithium; Mood Disorders; Receptors, Adrenergic, alpha; Tritium | 1983 |
Hyperserotonemia and platelet serotonin uptake and release in schizophrenia and affective disorders.
Topics: Adult; Bipolar Disorder; Blood Platelets; Chronic Disease; Depressive Disorder; Female; Humans; Lithium; Lithium Carbonate; Male; Middle Aged; Mood Disorders; Psychotic Disorders; Psychotropic Drugs; Schizophrenia; Serotonin | 1983 |
Carbamazepine and lithium carbonate in the treatment of refractory affective disorders.
Topics: Adult; Bipolar Disorder; Carbamazepine; Depressive Disorder; Humans; Lithium; Lithium Carbonate; Male; Mood Disorders | 1983 |
Reduced plasma and CSF gamma-aminobutyric acid in affective illness: effect of lithium carbonate.
Topics: Adult; Bipolar Disorder; Depressive Disorder; Female; gamma-Aminobutyric Acid; Humans; Lithium; Lithium Carbonate; Male; Mood Disorders | 1983 |
Subjective side effects of lithium carbonate: a longitudinal study.
Topics: Adult; Female; Humans; Lithium; Lithium Carbonate; Longitudinal Studies; Male; Mood Disorders; Personality Inventory | 1983 |
Drug plasma levels and platelet 5-HT uptake inhibition during long-term treatment with fluvoxamine or lithium in patients with affective disorders.
Topics: Antidepressive Agents; Blood Platelets; Double-Blind Method; Female; Fluvoxamine; Humans; Kinetics; Lithium; Male; Mood Disorders; Oximes; Serotonin | 1983 |
Effect of lithium therapy on glomerular filtration rate.
Topics: Adult; Bipolar Disorder; Creatinine; Female; Glomerular Filtration Rate; Humans; Lithium; Lithium Carbonate; Male; Mood Disorders | 1983 |
Sub-types of bipolar affective disorder with particular regard to bipolar II.
Topics: Adult; Bipolar Disorder; Catechol O-Methyltransferase; Diagnosis, Differential; Humans; Levodopa; Lithium; Lithium Carbonate; Mood Disorders; Suicide, Attempted | 1983 |
Saliva for monitoring of patients with primary affective disorders.
Topics: Female; Humans; Lithium; Lithium Carbonate; Male; Middle Aged; Monitoring, Physiologic; Mood Disorders; Psychotropic Drugs; Saliva; Salivary Glands; Salivation | 1984 |
Seizures activated by therapeutic levels of lithium carbonate.
Topics: Adult; Electroencephalography; Female; Humans; Lithium; Lithium Carbonate; Mood Disorders; Seizures | 1984 |
Development of an organic affective syndrome during a hyperbaric diving experiment.
Topics: Atmosphere Exposure Chambers; Bipolar Disorder; Diving; Humans; Hyperbaric Oxygenation; Lithium; Lithium Carbonate; Male; Mood Disorders; Neurocognitive Disorders; Psychological Tests; Stress, Psychological | 1984 |
Psychosis in anorexia nervosa and bulimia.
Topics: Adolescent; Adult; Anorexia Nervosa; Factitious Disorders; Feeding and Eating Disorders; Female; Humans; Hyperphagia; Lithium; Lithium Carbonate; Male; Mood Disorders; Psychotic Disorders | 1984 |
Cortisol changes in long-term lithium therapy.
Topics: Adult; Aged; Bipolar Disorder; Cyclothymic Disorder; Depressive Disorder; Dexamethasone; Female; Humans; Hydrocortisone; Lithium; Long-Term Care; Male; Middle Aged; Mood Disorders; Psychiatric Status Rating Scales; Psychotic Disorders | 1984 |
Antinuclear antibodies and histocompatibility antigens in patients on long-term lithium therapy.
Topics: Adult; Antibodies, Antinuclear; Blood Group Antigens; Female; HLA Antigens; Humans; Lithium; Male; Middle Aged; Mood Disorders; Time Factors | 1981 |
Lithium overview of practical considerations.
Topics: Acne Vulgaris; Administration, Oral; Agranulocytosis; Capsules; Cardiovascular Diseases; Central Nervous System Diseases; Goiter; Humans; Lithium; Lithium Carbonate; Mood Disorders; Schizophrenia; Stomatitis; Tablets | 1981 |
Prospective evaluation of two lithium maintenance dose schedules.
Topics: Adult; Half-Life; Humans; Hypnotics and Sedatives; Lithium; Mood Disorders; Sleep | 1984 |
[Lithium and other preventive agents of affective disorders in 1983].
Topics: Anticonvulsants; Humans; Lithium; Mood Disorders | 1984 |
Mood disorders.
Topics: Adolescent; Aged; Antidepressive Agents, Tricyclic; Child; Humans; Lithium; Mood Disorders | 1984 |
Rubidium in psychiatry: research implications.
Topics: Antidepressive Agents; Humans; Lithium; Mood Disorders; Rubidium; Schizophrenia | 1984 |
Neurological sequelae of lithium therapy.
Topics: Humans; Lithium; Male; Middle Aged; Mood Disorders; Nervous System Diseases; Psychomotor Disorders | 1984 |
[The prediction of therapeutic dosage of lithium].
Topics: Adolescent; Adult; Female; Humans; Kinetics; Lithium; Male; Middle Aged; Mood Disorders; Psychotic Disorders | 1984 |
Positron emission tomographic study of affective disorders: problems and strategies.
Topics: Bipolar Disorder; Depressive Disorder; Female; Glucose; Humans; Lithium; Male; Methylphenidate; Mood Disorders; Tomography, Emission-Computed | 1984 |
Plasma and red cell lithium in affective disorders.
Topics: Erythrocytes; Humans; Lithium; Mood Disorders | 1983 |
Memory functions during lithium therapy.
Topics: Adult; Female; Humans; Lithium; Male; Memory Disorders; Middle Aged; Mood Disorders; Psychiatric Status Rating Scales | 1983 |
The impact of therapeutic advances in widening the nosologic boundaries of affective disorders: clinical and research implications.
Topics: Aging; Alcoholism; Depressive Disorder; Humans; Lithium; Mood Disorders; Neurotic Disorders; Substance-Related Disorders | 1983 |
Influence of age on lithium therapy.
Topics: Adult; Age Factors; Bipolar Disorder; Humans; Lithium; Middle Aged; Mood Disorders | 1984 |
[Lithium in erythrocytes--model value and clinical relevance].
Topics: Bipolar Disorder; Cyclothymic Disorder; Dose-Response Relationship, Drug; Drug Administration Schedule; Erythrocytes; Female; Humans; Lithium; Middle Aged; Mood Disorders; Psychotic Disorders | 1984 |
Impairment of renal function in patients on long-term lithium treatment.
Topics: Adult; beta 2-Microglobulin; Female; Glomerular Filtration Rate; Humans; Kidney; Kidney Concentrating Ability; Lithium; Male; Middle Aged; Mood Disorders; Psychotic Disorders | 1982 |
[Further considerations on the use of lithium carbonate and the renal and thyroid disorders resulting from it].
Topics: Humans; Kidney Diseases; Lithium; Lithium Carbonate; Mood Disorders; Recurrence; Schizophrenia; Thyroid Diseases | 1980 |
Increased platelet monoamine oxidase activity in affective disorders.
Topics: Adult; Blood Platelets; Female; Humans; Lithium; Male; Middle Aged; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Mood Disorders; Sex Factors | 1981 |
Immunopotentiation and inhibition of herpes virus activation during therapy with lithium carbonate.
Topics: Adolescent; Adult; Female; Herpes Labialis; Humans; Immunity, Cellular; Immunologic Deficiency Syndromes; Lithium; Lithium Carbonate; Lymphocyte Activation; Male; Middle Aged; Mood Disorders; Prostaglandins E | 1981 |
Lithium prophylaxis of depression in unipolar, bipolar II, and cyclothymic patients.
Topics: Adult; Bipolar Disorder; Cyclothymic Disorder; Depressive Disorder; Female; Humans; Lithium; Lithium Carbonate; Male; Mood Disorders | 1982 |
Laboratory measurements in the clinical use of lithium.
Topics: Biomechanical Phenomena; Clinical Laboratory Techniques; Drug Resistance; Humans; Kidney Diseases; Lithium; Lithium Carbonate; Mood Disorders; Time Factors | 1982 |
Clinical significance of the interaction between lithium and a neuromuscular blocker.
Topics: Adult; Aged; Drug Synergism; Electroconvulsive Therapy; Female; Humans; Lithium; Lithium Carbonate; Male; Middle Aged; Mood Disorders; Succinylcholine; Thiopental | 1982 |
Prediction of lithium maintenance doses using a single point prediction protocol.
Topics: Adult; Humans; Lithium; Models, Biological; Mood Disorders; Time Factors | 1983 |
Lithium ion transport and affective disorders within families of bipolar patients. Identification of a major gene locus.
Topics: Alleles; Bipolar Disorder; Chromosome Mapping; Erythrocytes; Female; Hospitalization; Hospitals, Psychiatric; Humans; Lithium; Male; Mood Disorders; Polymorphism, Genetic | 1983 |
The effect of lithium on renal haemodynamic function.
Topics: Adult; Aged; Dopamine; Female; Glomerular Filtration Rate; Humans; Kidney Concentrating Ability; Lithium; Male; Middle Aged; Mood Disorders; Osmolar Concentration; Renal Circulation | 1983 |
Puerperal affective disorders and response to lithium.
Topics: Female; Humans; Lithium; Middle Aged; Mood Disorders; Pregnancy; Puerperal Disorders; Recurrence | 1983 |
Renal enzymes in lithium treatment.
Topics: Acetylglucosaminidase; Adult; Aged; Hexosaminidases; Humans; Lithium; Middle Aged; Mood Disorders | 1983 |
Psychotherapies and somatic therapies in affective disorders.
Topics: Antidepressive Agents; Bipolar Disorder; Depressive Disorder; Drug Therapy, Combination; Humans; Lithium; Mood Disorders; Outcome and Process Assessment, Health Care; Psychiatric Status Rating Scales; Psychotherapy | 1983 |
Lithium and electrolytes plasma/RBC ratio and paradoxical lithium neurotoxicity.
Topics: Adult; Electrolytes; Erythrocytes; Humans; Lithium; Middle Aged; Mood Disorders; Nervous System Diseases; Plasma | 1982 |
Lithium-induced hyperparathyroidism: an alteration of the "set-point".
Topics: Calcium; Humans; Hyperparathyroidism; Lithium; Male; Middle Aged; Mood Disorders; Parathyroid Hormone | 1982 |
Biological factors in affective disorders and their relevance to lithium prophylaxis.
Topics: Adoption; Circadian Rhythm; Erythrocyte Count; Humans; Lithium; Mood Disorders | 1982 |
Possible relationship between outcome in primary affective disorders treated with lithium and family history.
Topics: Aging; Bipolar Disorder; Female; Humans; Lithium; Male; Mood Disorders; Recurrence | 1982 |
Plasma lithium levels and therapeutic outcome in the prophylaxis of affective disorders: a retrospective study.
Topics: Adult; Aged; Female; Humans; Lithium; Male; Middle Aged; Mood Disorders; Recurrence; Retrospective Studies; Time Factors | 1982 |
Lithium in the prophylactic treatment of recurrent affective disorders.
Topics: Female; Humans; Lithium; Longitudinal Studies; Male; Mood Disorders; Recurrence | 1982 |
Effects of psychotropic drugs on hamster hibernation-pilot study.
Topics: Animals; Cricetinae; Hibernation; Humans; Imipramine; Lithium; Mesocricetus; Mood Disorders; Pilot Projects; Psychotropic Drugs | 1981 |
[Clinical chemical diagnosis of affective diseases by means of a neuroendocrine function test (author's transl)].
Topics: Adjustment Disorders; Blood Glucose; Depressive Disorder; Endocrine Glands; Female; Humans; Lithium; Middle Aged; Mood Disorders; Nervous System; Pituitary Hormones; Time Factors | 1980 |
Renal toxicity of lithium and its implications.
Topics: Aged; Female; Glomerular Filtration Rate; Humans; Kidney; Kidney Diseases; Kidney Tubules; Lithium; Male; Middle Aged; Mood Disorders | 1981 |
Biochemical markers identify mental states.
Topics: Glycols; Humans; Lithium; Methoxyhydroxyphenylglycol; Monoamine Oxidase; Mood Disorders | 1981 |
Genetics of affective disorders: new data and methods.
Topics: Affective Disorders, Psychotic; Arecoline; Blood Platelets; Dextroamphetamine; Humans; Lithium; Mood Disorders | 1981 |
Cell membrane predictors of response to lithium prophylaxis of affective disorders.
Topics: Adult; Affective Disorders, Psychotic; Aged; Bipolar Disorder; Erythrocyte Membrane; Erythrocytes; Female; HLA Antigens; Humans; Lithium; Male; Middle Aged; Mood Disorders | 1981 |
The effects of desmethylimipramine and lithium on human sperm function.
Topics: Adult; Desipramine; Humans; Lithium; Male; Middle Aged; Mood Disorders; Sperm Count; Sperm Motility; Spermatozoa | 1981 |
Phloretin-sensitive lithium transport in erythrocytes of affectively ill patients: intra-individual reproductibility.
Topics: Biological Transport; Erythrocytes; Humans; Individuality; Lithium; Mood Disorders; Phloretin | 1981 |
Lithium distribution ratios in psychiatrically normal subjects.
Topics: Adult; Bipolar Disorder; Erythrocytes; Female; Humans; Lithium; Male; Mood Disorders; Plasma; Potassium; Reference Values; Sodium | 1980 |
Lithium and platelets.
Topics: Biological Transport; Blood Platelets; Humans; Lithium; Mood Disorders | 1980 |
Cognitive and affective functions in patients with affective disorders treated with lithium. An assessment by questionnaire.
Topics: Age Factors; Cognition; Emotions; Humans; Lithium; Mood Disorders; Surveys and Questionnaires; Triiodothyronine | 1980 |
Sensitization and oscillation following repeated stimulation: relationship to affective illness and its treatment with lithium and carbamazepine [proceedings].
Topics: Animals; Carbamazepine; Humans; Lithium; Mood Disorders | 1980 |
Lithium elimination half-life and duration of therapy.
Topics: Female; Half-Life; Humans; Lithium; Male; Middle Aged; Mood Disorders; Time Factors | 1981 |
Excess cardiovascular and suicide mortality of affective disorders may be reduced by lithium prophylaxis.
Topics: Cardiovascular Diseases; Female; Humans; Lithium; Male; Mood Disorders; Suicide Prevention | 1995 |
Lithium in steroid-induced depression.
Topics: Adrenal Cortex Hormones; Adult; Carbamazepine; Female; Humans; Lithium; Mood Disorders | 1995 |
Kidney damage in long-term lithium patients: a cross-sectional study of patients with 15 years or more on lithium.
Topics: Adult; Aged; Aged, 80 and over; Cross-Sectional Studies; Female; Glomerular Filtration Rate; Humans; Kidney Concentrating Ability; Kidney Diseases; Kidney Glomerulus; Kidney Tubules; Lithium; Long-Term Care; Male; Middle Aged; Mood Disorders; Prevalence | 1994 |
Choosing lithium, anticonvulsant, or electroconvulsant therapy for mood disorders.
Topics: Anticonvulsants; Bipolar Disorder; Electroconvulsive Therapy; Electroencephalography; Forecasting; Humans; Lithium; Mood Disorders; Patient Selection | 1995 |
Choosing lithium, anticonvulsant, or electroconvulsant therapy for mood disorders.
Topics: Anticonvulsants; Bipolar Disorder; Carbamazepine; Controlled Clinical Trials as Topic; Electroconvulsive Therapy; Humans; Lithium; Mood Disorders; Valproic Acid | 1995 |
Lithium in the treatment of mood disorders.
Topics: Drug Overdose; Humans; Lithium; Mood Disorders | 1995 |
CSF magnesium in affective disorder: lack of correlation with clinical course of treatment.
Topics: Adult; Carbamazepine; Female; Humans; Lithium; Magnesium; Male; Mood Disorders; Sex Factors; Spinal Puncture | 1994 |
Effect of antidopaminergic drugs on endogenous digoxin-like factor in psychiatric patients.
Topics: Adult; Aldosterone; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Blood Proteins; Cardenolides; Case-Control Studies; Creatinine; Digoxin; Dopamine; Dopamine Antagonists; Female; Humans; Lithium; Male; Mood Disorders; Radioimmunoassay; Renin-Angiotensin System; Saponins; Schizophrenia; Sodium-Potassium-Exchanging ATPase; Water-Electrolyte Balance | 1993 |
[Dynamics of platelet serotonin levels in affective disorders].
Topics: Blood Platelets; Female; Humans; Hydroxybutyrates; Lithium; Male; Mood Disorders; Organometallic Compounds; Serotonin | 1994 |
Lithium ratio, phospholipids and the incidence of side effects.
Topics: Adolescent; Adult; Aged; Drug Carriers; Female; Humans; Hypothalamus; Liposomes; Lithium; Male; Middle Aged; Mood Disorders; Phospholipids; Prognosis; Psychiatric Status Rating Scales; Water-Electrolyte Balance | 1994 |
Length of lithium treatment needed to eliminate the high mortality of affective disorders.
Topics: Confidence Intervals; Female; Germany; Humans; Lithium; Male; Mood Disorders; Mortality; Psychiatric Status Rating Scales; Suicide; Suicide Prevention; Time Factors; Treatment Outcome | 1993 |
Predictors of response to lithium and triiodothyronine augmentation of antidepressants in tricyclic non-responders.
Topics: Adult; Ambulatory Care; Antidepressive Agents, Tricyclic; Double-Blind Method; Drug Resistance; Female; Humans; Lithium; Male; Middle Aged; Mood Disorders; Sleep Wake Disorders; Thyroid Function Tests; Triiodothyronine; Weight Loss | 1993 |
A study of relapses in subjects with mood disorder on lithium treatment.
Topics: Aging; Bipolar Disorder; Depressive Disorder; Female; Humans; Lithium; Male; Middle Aged; Mood Disorders; Personality Disorders; Psychiatric Status Rating Scales; Recurrence; Treatment Outcome | 1993 |
[A study of red cell sodium-lithium countertransport in affective disorders].
Topics: Adult; Aged; Biological Transport; Erythrocyte Membrane; Feeding and Eating Disorders; Female; Humans; Lithium; Male; Middle Aged; Mood Disorders; Sodium | 1993 |
A cross-sectional study of parkinsonism and tardive dyskinesia in lithium-treated affective disordered patients.
Topics: Adult; Aged; Ambulatory Care; Antipsychotic Agents; Bipolar Disorder; Cross-Sectional Studies; Depressive Disorder; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Female; Humans; Lithium; Male; Middle Aged; Mood Disorders; Parkinson Disease, Secondary; Prevalence; Psychiatric Status Rating Scales; Regression Analysis; Treatment Outcome | 1996 |
Six-year follow-up of thyroid function during lithium treatment.
Topics: Antibodies; Anticonvulsants; Antipsychotic Agents; Carbamazepine; Drug Therapy, Combination; Female; Follow-Up Studies; Goiter; Humans; Hypothyroidism; Lithium; Male; Mood Disorders; Retrospective Studies; Thyroid Gland; Thyrotropin; Ultrasonography | 1996 |
Lithium side effects in relation to brain lithium concentration measured by lithium-7 magnetic resonance spectroscopy.
Topics: Adult; Brain; Female; Humans; Lithium; Magnetic Resonance Spectroscopy; Male; Middle Aged; Mood Disorders | 1996 |
Lithium-responsive affective disorders: no association with the tyrosine hydroxylase gene.
Topics: Adult; Aged; Alleles; Antidepressive Agents; Chromosomes, Human, Pair 11; Female; Genotype; Humans; Lithium; Male; Middle Aged; Mood Disorders; Tyrosine 3-Monooxygenase | 1996 |
Mortality studies and the effectiveness of drugs in long-term treatment.
Topics: Antimanic Agents; Clinical Trials, Phase IV as Topic; Drug Monitoring; Humans; Lithium; Mood Disorders; Psychotropic Drugs; Research Design | 1997 |
Nephrogenic diabetes insipidus in a lethargic lithium-treated patient.
Topics: Aged; Aged, 80 and over; Antidepressive Agents; Brain; Diabetes Insipidus, Nephrogenic; Humans; Lithium; Lithium Carbonate; Male; Mood Disorders; Sleep Stages | 1997 |
Autosomal recessive inheritance of affective disorders in families of responders to lithium prophylaxis?
Topics: Adult; Aged; Alleles; Antidepressive Agents; Chromosome Aberrations; Chromosome Disorders; Female; Humans; Lithium; Male; Middle Aged; Mood Disorders; X Chromosome | 1997 |
Nephrotic syndrome during lithium therapy.
Topics: Adult; Female; Humans; Lithium; Mood Disorders; Nephrotic Syndrome | 1997 |
Suicide mortality in patients on lithium maintenance therapy.
Topics: Cohort Studies; Female; Humans; Incidence; Lithium; Male; Middle Aged; Mood Disorders; Risk Factors; Suicide | 1998 |
Vitamin B12 and folate levels and lithium administration in patients with affective disorders.
Topics: Adult; Aged; Antidepressive Agents; Dose-Response Relationship, Drug; Female; Folic Acid; Humans; Lithium; Male; Middle Aged; Mood Disorders; Vitamin B 12 | 1999 |
Lithium prevents suicide.
Topics: Bipolar Disorder; Humans; Lithium; Mood Disorders; Suicide Prevention | 1999 |
Lithium therapy and suicide risk.
Topics: Cause of Death; Female; Follow-Up Studies; Hospitalization; Humans; Lithium; Male; Mass Screening; Middle Aged; Mood Disorders; Psychotic Disorders; Risk Factors; Substance Withdrawal Syndrome; Suicide; Sweden | 1999 |
Effects of medical interventions on suicidal behavior. Summary and conclusions.
Topics: Anticonvulsants; Carbamazepine; Comorbidity; Depressive Disorder; Health Education; Humans; Lithium; Mental Disorders; Mood Disorders; Risk Factors; Substance-Related Disorders; Suicide; Suicide Prevention | 1999 |
Introduction: the use of mood stabilizers in the treatment of psychiatric disorders.
Topics: Anticonvulsants; Antimanic Agents; Antipsychotic Agents; Bipolar Disorder; Carbamazepine; Humans; Lithium; Mental Disorders; Mood Disorders; Valproic Acid | 1999 |
Trace lithium in mood disorders.
Topics: Antimanic Agents; Cell Membrane; Erythrocytes; Humans; Lithium; Mood Disorders; Prospective Studies; Spectrophotometry, Atomic; Surveys and Questionnaires | 1999 |
5-HT1B receptors: a novel target for lithium. Possible involvement in mood disorders.
Topics: 3T3 Cells; Animals; Antidepressive Agents; Binding, Competitive; Blood Platelets; Cations; CHO Cells; Cricetinae; Dose-Response Relationship, Drug; Guanosine 5'-O-(3-Thiotriphosphate); Guinea Pigs; Humans; Lithium; Mice; Mood Disorders; Psychomotor Performance; Rats; Receptor, Serotonin, 5-HT1B; Receptors, Serotonin; Serotonin; Serotonin Antagonists; Sulfur Radioisotopes; Synaptosomes | 1999 |
Early onset of lithium prophylaxis as a predictor of good long-term outcome.
Topics: Adult; Age Factors; Antipsychotic Agents; Female; Humans; Lithium; Male; Middle Aged; Mood Disorders; Retrospective Studies; Secondary Prevention; Survival Analysis; Time Factors; Treatment Outcome | 1999 |
Lithium therapy and signal transduction.
Topics: Brain; Calcium-Calmodulin-Dependent Protein Kinases; Cells, Cultured; Depression; Glycogen Synthase Kinase 3; Glycogen Synthase Kinases; Humans; Inositol 1,4,5-Trisphosphate; Lithium; Mood Disorders; Neural Pathways; Prolyl Oligopeptidases; Proto-Oncogene Proteins; Serine Endopeptidases; Signal Transduction; Wnt Proteins; Zebrafish Proteins | 2000 |
How effective is long-term lithium prophylaxis?
Topics: Antimanic Agents; Humans; Lithium; Mood Disorders; Treatment Outcome | 2000 |
In vivo imaging of the pharmacodynamics and pharmacokinetics of lithium.
Topics: Brain; Brain Chemistry; Diagnostic Imaging; Humans; Isotopes; Lithium; Magnetic Resonance Spectroscopy; Mood Disorders; Neuroprotective Agents; Signal Transduction | 2000 |
Recurrent cases of corticosteroid-induced mood disorder: clinical characteristics and treatment.
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Aged; Anticonvulsants; Antidepressive Agents; Antipsychotic Agents; Bipolar Disorder; Depressive Disorder; Female; Humans; Lithium; Male; Methylprednisolone; Middle Aged; Mood Disorders; Psychiatry; Pulse Therapy, Drug; Recurrence; Referral and Consultation | 2000 |
Lithium therapy.
Topics: Diabetes Insipidus; Female; Half-Life; Humans; Lithium; Mood Disorders; Pregnancy; Teratogens; Tissue Distribution | 2000 |
Lithium therapy for corticosteroid-induced mood disorder.
Topics: Acute Disease; Adrenal Cortex Hormones; Antidepressive Agents, Tricyclic; Clomipramine; Comorbidity; Contraindications; Depressive Disorder; Drug Administration Schedule; Humans; Hypothyroidism; Kidney Diseases; Lithium; Mood Disorders; Treatment Outcome | 2001 |
50 years of lithium treatment of mood disorders.
Topics: History, 20th Century; Humans; Lithium; Mood Disorders | 1999 |
[The mechanism of enhanced platelet intracellular calcium mobilization stimulated by serotonin--in the pathophysiology of mood disorders].
Topics: Adult; Antidepressive Agents; Blood Platelets; Calcium; Calmodulin; Female; Humans; Lithium; Male; Mood Disorders; Protein Kinase C; Receptor, Serotonin, 5-HT2A; Receptors, Serotonin; Serotonin; Signal Transduction | 2001 |
Serotonin transporter gene associated with lithium prophylaxis in mood disorders.
Topics: Adult; Aged; Carrier Proteins; Female; Follow-Up Studies; Genotype; Humans; Lithium; Male; Membrane Glycoproteins; Membrane Transport Proteins; Middle Aged; Mood Disorders; Nerve Tissue Proteins; Prospective Studies; Serotonin Plasma Membrane Transport Proteins | 2001 |
Pharmacogenetics of lithium prophylaxis in mood disorders: analysis of COMT, MAO-A, and Gbeta3 variants.
Topics: Adult; Catechol O-Methyltransferase; Female; Heterotrimeric GTP-Binding Proteins; Humans; Lithium; Male; Middle Aged; Monoamine Oxidase; Mood Disorders; Treatment Outcome | 2002 |
Serum drug level monitoring in affective disorders.
Topics: Carbamazepine; Dose-Response Relationship, Drug; Humans; Lithium; Monitoring, Physiologic; Mood Disorders | 1992 |
Lithium treatment of affective disorders: effects of lithium on the inositol phospholipid and cyclic AMP signalling pathways.
Topics: Animals; Carbachol; Cerebral Cortex; Chromatography, High Pressure Liquid; Cyclic AMP; Cyclic CMP; Inositol Phosphates; Lithium; Male; Mood Disorders; Norepinephrine; Phospholipids; Phosphoric Diester Hydrolases; Rats; Rats, Inbred Strains; Signal Transduction | 1992 |
Completed suicide and recent lithium treatment.
Topics: Adult; Female; Finland; Humans; Lithium; Male; Mood Disorders; Psychiatric Status Rating Scales; Retrospective Studies; Sex Factors; Suicide; Treatment Refusal | 1992 |
Lithium and mortality: a 15 year follow-up.
Topics: England; Follow-Up Studies; Humans; Lithium; Mood Disorders; Suicide; Wales | 1992 |
Impact of affective illness on gene expression: implications for early and long-term prophylaxis.
Topics: Antidepressive Agents; Gene Expression Regulation; Humans; Lithium; Mood Disorders | 1992 |
Serum amylase in patients treated with lithium.
Topics: Aged; Amylases; Female; Humans; Lithium; Male; Middle Aged; Mood Disorders | 1990 |
[Pseudo-schizophrenic forms of mood disorders].
Topics: Adult; Antidepressive Agents; Clomipramine; Diagnosis, Differential; Drug Therapy, Combination; Female; Humans; Lithium; Male; Mood Disorders; Schizophrenia | 1991 |
Vaginal ulcerations due to lithium carbonate therapy.
Topics: Acne Vulgaris; Adult; Female; Humans; Leg Dermatoses; Lichen Planus; Lithium; Lithium Carbonate; Mood Disorders; Thigh; Ulcer; Vaginal Diseases | 1991 |
Diltiazem-induced psychosis and a possible diltiazem-lithium interaction.
Topics: Aged; Diltiazem; Drug Synergism; Female; Humans; Hypertension; Lithium; Lithium Carbonate; Mood Disorders; Psychoses, Substance-Induced | 1991 |
Understanding psychotropic drugs.
Topics: Adult; Depressive Disorder; Emergencies; Female; Humans; Lithium; Mood Disorders; Phenelzine | 1991 |
Tardive dyskinesia and lithium.
Topics: Antipsychotic Agents; Dyskinesia, Drug-Induced; Humans; Lithium; Mood Disorders; Risk Factors; Schizophrenia | 1990 |
Long-term lithium and mortality.
Topics: England; Humans; Lithium; Mood Disorders; Morbidity; Suicide; Wales | 1990 |
Lithium treatment of cocaine addiction.
Topics: Cocaine; Humans; Lithium; Mood Disorders; Self Medication; Substance-Related Disorders | 1991 |
The effect of lithium therapy on parameters thought to be involved in the development of autoimmune thyroid disease.
Topics: Adult; Autoantibodies; Autoimmune Diseases; B-Lymphocytes; Bipolar Disorder; Female; Humans; Lithium; Male; Microsomes; Mood Disorders; T-Lymphocytes; Thyroglobulin; Thyroid Diseases | 1991 |
Mode of action of lithium in affective disorders. An influence on intracellular calcium functions.
Topics: Adenosine Triphosphatases; Adult; Aged; Aged, 80 and over; Brain Chemistry; Calcium; Calmodulin; Deoxyglucose; Enzyme Activation; Female; Humans; Inosine Triphosphate; Kinetics; Lithium; Male; Membranes; Middle Aged; Models, Biological; Mood Disorders; Phosphoproteins | 1990 |
A possible antiviral action of lithium carbonate in herpes simplex virus infections.
Topics: Adult; Antidepressive Agents; Antiviral Agents; Female; Herpes Labialis; Humans; Lithium; Lithium Carbonate; Male; Middle Aged; Mood Disorders; Recurrence; Retrospective Studies; Simplexvirus | 1990 |
The presence of antithyroid antibodies in patients with affective and nonaffective psychiatric disorders.
Topics: Adolescent; Adult; Aged; Autoantibodies; Bipolar Disorder; Depressive Disorder; Female; Humans; Lithium; Male; Mental Disorders; Middle Aged; Mood Disorders; Thyroid Function Tests; Thyroid Gland; Thyroiditis, Autoimmune | 1990 |
Pharmacokinetics of lithium in patients treated with controlled release lithium formulations.
Topics: Adult; Aged; Delayed-Action Preparations; Female; Humans; Lithium; Male; Middle Aged; Mood Disorders | 1990 |
Effects of chronic treatment with trihexyphenidyl and carbamazepine alone or in combination with haloperidol on substance P content in rat brain: a possible implication of substance P in affective disorders.
Topics: Animals; Body Weight; Brain Chemistry; Carbamazepine; Dopamine; Dose-Response Relationship, Drug; gamma-Aminobutyric Acid; Glutamates; Glutamic Acid; Haloperidol; Lithium; Male; Mood Disorders; Rats; Rats, Inbred Strains; Serotonin; Substance P; Trihexyphenidyl | 1988 |
GABAB receptors are up-regulated by chronic treatment with lithium or carbamazepine. GABA hypothesis of affective disorders?
Topics: Animals; Baclofen; Carbamazepine; Cerebral Cortex; gamma-Aminobutyric Acid; Hippocampus; Lithium; Male; Mood Disorders; Muscimol; Rats; Rats, Inbred WKY; Receptors, GABA-A; Synaptic Membranes | 1989 |
Effect of in vivo lithium treatment on (-)isoproterenol-stimulated cAMP accumulation in lymphocytes of healthy subjects and patients with affective psychoses.
Topics: Adult; Bipolar Disorder; Cyclic AMP; Female; Humans; Isoproterenol; Lithium; Lymphocytes; Male; Middle Aged; Mood Disorders; Neutrophils | 1989 |
[A follow-up study on rapid cycling affective disorders].
Topics: Adolescent; Adult; Aged; Carbamazepine; Cyclothymic Disorder; Female; Follow-Up Studies; Humans; Lithium; Male; Middle Aged; Mood Disorders; Recurrence | 1989 |
Computerized documentation for lithium outpatients (routine and research data).
Topics: Computers; Documentation; Electroencephalography; Humans; Lithium; Mood Disorders | 1989 |
Lithium treatment of a patient with Addison's disease and affective psychosis.
Topics: Addison Disease; Female; Humans; Lithium; Middle Aged; Mood Disorders; Virus Diseases | 1989 |
Treatment of mood disorder associated with Binswanger's disease.
Topics: Aged; Amitriptyline; Dementia, Vascular; Humans; Lithium; Male; Mood Disorders | 1989 |
Lithium in the prophylaxis of affective disorders: a twenty years experience.
Topics: Humans; Lithium; Mood Disorders | 1989 |
Saliva lithium: a poor predictor of plasma and erythrocyte levels.
Topics: Adult; Erythrocytes; Evaluation Studies as Topic; Female; Humans; Lithium; Male; Middle Aged; Monitoring, Physiologic; Mood Disorders; Prognosis; Reference Values; Saliva | 1989 |
Role of receptor coupling to phosphoinositide metabolism in the therapeutic action of lithium.
Topics: Animals; Brain; Homeostasis; Humans; Lithium; Models, Neurological; Mood Disorders; Phosphatidylinositols; Receptors, Cell Surface | 1987 |
Mania with emotional blunting: affective disorder or schizophrenia?
Topics: Adult; Age Factors; Alcoholism; Antipsychotic Agents; Bipolar Disorder; Diagnosis, Differential; Female; Hospitalization; Humans; Lithium; Male; Mood Disorders; Psychiatric Status Rating Scales; Psychotic Disorders; Risk; Schizophrenia; Schizophrenic Psychology | 1985 |
Serum neuroleptic levels and extrapyramidal side effects in patients treated with amoxapine.
Topics: Adult; Amoxapine; Antipsychotic Agents; Basal Ganglia Diseases; Dibenzoxazepines; Dose-Response Relationship, Drug; Drug Interactions; Drug Therapy, Combination; Humans; Lithium; Middle Aged; Mood Disorders; Schizophrenia | 1985 |
Descriptive, biological, and theoretical aspects of borderline personality disorder.
Topics: Animals; Antipsychotic Agents; Borderline Personality Disorder; Dexamethasone; Haplorhini; Humans; Lithium; Mood Disorders; Neurocognitive Disorders; Personality Disorders; Sleep, REM; Thyrotropin | 1986 |
Everyday management of affective disorders.
Topics: Aged; Ambulatory Care Facilities; Drug Evaluation; England; Humans; Lithium; Lithium Carbonate; Long-Term Care; Mood Disorders | 1987 |
RBC-choline: a biological marker of the outcome of lithium prophylaxis?
Topics: Alcoholism; Antidepressive Agents; Antipsychotic Agents; Bipolar Disorder; Choline; Erythrocytes; Humans; Lithium; Mood Disorders; Schizophrenia | 1987 |
Polydipsia, hyponatremia, and psychosis.
Topics: Carbamazepine; Drinking; Drug Therapy, Combination; Humans; Hyponatremia; Inappropriate ADH Syndrome; Lithium; Mood Disorders; Substance Withdrawal Syndrome | 1989 |
Opioid peptides and receptors in relation to affective illness. Effects of desipramine and lithium on opioid receptors in rat brain.
Topics: Animals; Brain; Brain Chemistry; Desipramine; Electroshock; Endorphins; Humans; In Vitro Techniques; Lithium; Mood Disorders; Rats; Receptors, Opioid | 1985 |
The treatment of psychotic symptoms in Fahr's disease with lithium carbonate.
Topics: Adult; Basal Ganglia Diseases; Brain; Calcinosis; Dementia; Humans; Kyphosis; Lithium; Lithium Carbonate; Male; Mood Disorders; Movement Disorders; Psychotic Disorders; Scoliosis; Tomography, X-Ray Computed | 1986 |
The utility of a single-point dosing protocol for predicting steady-state lithium levels.
Topics: Adult; Drug Administration Schedule; Humans; Lithium; Lithium Carbonate; Models, Biological; Mood Disorders; Prospective Studies | 1986 |
Adherence to lithium prophylaxis: II. Multivariate analysis of clinical, social, and psychosocial predictors of nonadherence.
Topics: Adult; Age Factors; Employment; Family; Female; Humans; Lithium; Male; Mood Disorders; Patient Compliance; Sex Factors; Socioeconomic Factors | 1988 |
Lithium-induced renal disease: a prospective study.
Topics: Adult; Aged; Blood Urea Nitrogen; Creatinine; Female; Glomerular Filtration Rate; Humans; Kidney Concentrating Ability; Kidney Diseases; Lithium; Male; Middle Aged; Mood Disorders; Prospective Studies; Sex Factors | 1988 |
Long-term therapy of affective disorders: monotherapy or polypharmacy?
Topics: Antidepressive Agents; Bipolar Disorder; Chronic Disease; Depressive Disorder; Drug Therapy, Combination; Drug Utilization; Female; Humans; Lithium; Male; Middle Aged; Mood Disorders | 1988 |
Prophylactic lithium treatment: treatment response, and patient attitudes toward illness and treatment.
Topics: Adult; Antidepressive Agents; Drug Therapy, Combination; Female; Humans; Lithium; Male; Mood Disorders; Psychotic Disorders; Recurrence | 1988 |
Electrooculography and dark adaptation in patients with affective and schizoaffective psychoses: early physiological effects of carbamazepine and lithium.
Topics: Adult; Aged; Aged, 80 and over; Carbamazepine; Dark Adaptation; Electrooculography; Female; Humans; Lithium; Male; Middle Aged; Mood Disorders; Psychotic Disorders | 1988 |
Quality of interepisodic periods in patients with affective disorders under long-term lithium treatment.
Topics: Adult; Female; Humans; Lithium; Male; Middle Aged; Mood Disorders; Psychotic Disorders | 1988 |
Rapid cycling affective disorder: contributing factors and treatment responses in 51 patients.
Topics: Adult; Antidepressive Agents; Bipolar Disorder; Female; Hospitalization; Humans; Lithium; Male; Menstruation; Middle Aged; Monoamine Oxidase Inhibitors; Mood Disorders; Sex Factors; Thyroid Diseases | 1988 |
Carbamazepine and hyponatremia.
Topics: Carbamazepine; Drug Therapy, Combination; Humans; Hyponatremia; Lithium; Mood Disorders | 1988 |
Red blood cell plasma Li ratio variability in affective patients.
Topics: Adult; Female; Humans; Lithium; Male; Middle Aged; Mood Disorders; Recurrence | 1987 |
[A clinical study on combined lithium and carbamazepine treatment of major affective disorders].
Topics: Adult; Carbamazepine; Drug Therapy, Combination; Female; Humans; Lithium; Male; Mood Disorders; Recurrence | 1987 |
Amelioration by indomethacin of lithium-induced polyuria.
Topics: Adult; Diabetes Insipidus; Female; Humans; Indomethacin; Lithium; Mood Disorders; Polyuria | 1987 |
Lithium: long-term effects on the kidney. III. Prospective study.
Topics: Adult; Aged; Creatinine; Female; Glomerular Filtration Rate; Humans; Kidney; Kidney Concentrating Ability; Kidney Function Tests; Kidney Glomerulus; Kidney Tubules; Lithium; Male; Middle Aged; Mood Disorders; Prospective Studies; Urination | 1987 |
Neuroendocrine factors in affective disorders.
Topics: Carbamazepine; Humans; Lithium; Mood Disorders; Neurosecretory Systems | 1987 |
Lithium: long-term effects on the kidney. IV. Renal lithium clearance.
Topics: Adult; Aged; Female; Glomerular Filtration Rate; Humans; Kidney; Lithium; Male; Metabolic Clearance Rate; Middle Aged; Mood Disorders | 1987 |
Symptoms of neuroleptic malignant syndrome in 82 consecutive inpatients.
Topics: Adolescent; Adult; Hospital Records; Hospitalization; Humans; Lithium; Male; Mood Disorders; Neuroleptic Malignant Syndrome; Retrospective Studies | 1986 |
Mood-independent aberrancies in associative processes in bipolar affective disorder: an apparent stabilizing effect of lithium.
Topics: Adult; Affect; Affective Disorders, Psychotic; Association; Bipolar Disorder; Cyclothymic Disorder; Depressive Disorder; Female; Humans; Lithium; Male; Mood Disorders; Psychotic Disorders; Word Association Tests | 1985 |
The impact of lithium in South-west Scotland. I. Demographic and clinical findings.
Topics: Adolescent; Adult; Aged; Bipolar Disorder; Body Weight; Cross-Sectional Studies; Depressive Disorder; Female; Hair; Humans; Lithium; Male; Memory Disorders; Middle Aged; Mood Disorders; Schizophrenia; Scotland; Urination Disorders | 1985 |
Long-term lithium treatment. Some clinical, psychological and biological aspects.
Topics: Adult; Arousal; Bipolar Disorder; Calcium; Cyclothymic Disorder; Depressive Disorder; Female; Humans; Lithium; Long-Term Care; Magnesium; Male; Middle Aged; Mood Disorders; Personality Inventory; Psychiatric Status Rating Scales; Psychotic Disorders | 1985 |
Pharmacologic evidence for specificity of pursuit dysfunction to schizophrenia. Lithium carbonate associated with abnormal pursuit.
Topics: Adult; Ambulatory Care; Depressive Disorder; Eye Movements; Hospitalization; Humans; Lithium; Lithium Carbonate; Mood Disorders; Schizophrenia | 1985 |
[Course and form variations of cyclothymic phases in lithium therapy].
Topics: Bipolar Disorder; Cyclothymic Disorder; Humans; Lithium; Long-Term Care; Mood Disorders | 1985 |
Mood disorders: pharmacologic prevention of recurrences. A National Institutes of Health consensus report synopsis.
Topics: Adult; Antidepressive Agents; Female; Humans; Lithium; Male; Mood Disorders; National Institutes of Health (U.S.); Recurrence; United States | 1985 |
Amelioration of polyuria by amiloride in patients receiving long-term lithium therapy.
Topics: Adult; Amiloride; Body Water; Electrolytes; Female; Follow-Up Studies; Humans; Kidney Concentrating Ability; Kidney Tubules, Collecting; Lithium; Male; Middle Aged; Mood Disorders; Osmolar Concentration; Polyuria; Pyrazines | 1985 |
NIMH/NIH Consensus Development Conference statement. Mood disorders: pharmacologic prevention of recurrences. Consensus Development Panel.
Topics: Antidepressive Agents, Tricyclic; Bipolar Disorder; Counseling; Depressive Disorder; Humans; Lithium; Mood Disorders; National Institute of Mental Health (U.S.); National Institutes of Health (U.S.); Patient Compliance; Psychotherapy; Recurrence; Risk; United States | 1985 |
RBC choline and renal disorders during lithium treatment.
Topics: Adult; Aged; Choline; Erythrocytes; Female; Humans; Kidney Concentrating Ability; Lithium; Male; Middle Aged; Mood Disorders; Osmolar Concentration; Urine | 1985 |
The impact of lithium in South-west Scotland. II. A longitudinal study.
Topics: Adolescent; Adult; Aged; Antidepressive Agents; Electroconvulsive Therapy; Female; Hospitalization; Humans; Lithium; Longitudinal Studies; Male; Middle Aged; Mood Disorders; Scotland | 1985 |
Transient sensory, cognitive and affective phenomena in affective illness. A comparison with complex partial epilepsy.
Topics: Adult; Antidepressive Agents, Tricyclic; Cognition Disorders; Epilepsy; Female; Humans; Lithium; Male; Middle Aged; Mood Disorders; Perceptual Disorders; Sensation | 1985 |
The impact of lithium in South-West Scotland. III. The discontinuation of lithium.
Topics: Adult; Aged; Ataxia; Female; Humans; Lithium; Male; Middle Aged; Mood Disorders; Patient Compliance; Scotland; Tremor | 1985 |
Consensus development summaries. Mood disorders: pharmacologic prevention of recurrences. National Institutes of Health.
Topics: Antidepressive Agents, Tricyclic; Humans; Lithium; Mood Disorders; National Institutes of Health (U.S.); Recurrence; United States | 1985 |
Investigations of melatonin secretion in man.
Topics: Adolescent; Adult; Circadian Rhythm; Female; Humans; Lithium; Male; Melatonin; Middle Aged; Mood Disorders | 1985 |
[Lithium and hypothyroidism].
Topics: Adult; Female; Humans; Hypothyroidism; Lithium; Male; Mood Disorders | 1985 |